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Meeting report of the European Histamine Research Society
G. Sturman
The 40th meeting of the European Histamine Research
Society was the second time we have met in Russia; the
previous meeting being in 1995 in Moscow. This year the
meeting was at the kind invitation of Professor Roman
Khanferyan of Kuban State Medical University, Krasnodar,
Russia and took place between 11 and 14th May 2011 at
the Neva International Hotel, Sochi. Sochi, the largest
resort of the Russian Federation, is situated on the eastern
side of the Black Sea and will host the XXII Olympic
Winter Games in 2014. This was the most easterly meeting
our society has ever held. This year there were fewer
delegates attending but they represented 11 countries (most
from the European countries, especially Russia but also
from North and South America and Japan). Some of the
regular EHRS attendees could not be there and they were
missed but a big welcome was given to all the new visitors,
who we hope will return to future meetings.
Most delegates arrived during the Wednesday. As usual
the Council held their meeting late afternoon before the
Welcome Session. Our actual meeting was held in the
hotels nightclub which had some easy chairs and sofas in
the back row; a first for our society’s meetings! Roman
welcomed everyone and including those people from the
European Academy of Allergy and Clinical Immunology.
There was a welcome speech by Alexander Chuchalin, on
behalf of the Russian Ministry of Health. Then we listened
to a very special lecture given by Professor Wilfred Lorenz
(Germany), one of our Honorary Members to celebrate our
special anniversary. His presentation was entitled
‘EHRS—Birth of the Histamine Club’. At the end of this
delightful talk, Wilfred was given a little present to thank
him. Then we listened to the first plenary lecture given by
Nikos Papadopoulos (Greece) on ‘Viruses and Asthma’.
Then we moved to the restaurant for our Welcome
Reception. There was a three piece band, which played for
us while we nibbled on a wonderful array of canapés and
drank local wines and, of course, vodka. We were able to
wander and sit outside in the delightful water garden. In the
corner of this garden, a couple of barbeques cooked for us.
Old friends were greeted again whilst new ones were made.
On the Thursday, we started the meeting with the
Opening Ceremony. We started with an introduction from
our host Roman Khanferyan. Then the Mayor of Sochi
talked about the developments of Sochi for the next winter
Olympic Games in 2014. This was followed by the Head of
the Russian Society of Immunology welcoming us to
Russia. Then our president, Anita Sydbom gave her wel-
coming talk, which centred round Russian folk customs,
especially folk dances. She then outlined the programme of
this meeting. She then presented the student bursaries;
certificates and cheques (each for €500) to six student
members. Pfizer sponsored 2, while the G.B.West Memo-
rial Trust gave another. The El-Sayed Assem family
sponsored 2 more and the remaining one was from our
society. Anita introduced the second of our plenary lectures
which was given by Marek Jutel (Poland) and was entitled
‘H1/H2 receptors in allergic and immune response’. After
this very interesting lecture, the first of the oral sessions on
Histamine in Allergy began. Like last year, each oral ses-
sion at this meeting was chaired by an experience scientist
as well as a young EHRS member so that they could get
experience of chairing oral sessions. Just before our coffee
break we had a group photograph taken. Then we listened
to an oral session on Histamine H3 and H4 receptors,
followed by one on Histamine and Metabolism, and then
on Histamine H4 Receptor and Immune Response. During
the afternoon, we were able to view all the four posters
sessions. One of the posters was a special one produced by
Madeleine Ennis, one of our honorary members, celebrat-
ing our 40 years as a society with lots of photos of our
highlights and history. The poster committee as usual had a
difficult task in identifying winning posters for the poster
competition. Eventually first prize was given to M. Kurnik
et al. from Krakow, Poland, second to T. Karcz et al., also
from Krakow and third prize to the Mexican group
(Angelica Osorio-Espinoza et al.). In the evening we were
taken to the City Concert Hall in the centre of Sochi where
we listened to the Black Sea Jazz Group (Sergei Jemla-
nykhin, Sergei Kokorin, Rodion Latyshev, Vladimir
Gritzai and Irina Babicheva) together with Robert
Anchipolovsky (Israel) on saxophone. Because of the very
high increase in humidity, the planned band was unable to
fly into Sochi airport which was closed for a total of 4 days.
Thus we all marvelled at Roman’s ability to get this
excellent band at such short notice. Of course, Roman
ended up playing the piano with these musicians.
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Friday began with the G.B. West lecture which was
given by Robin Thurmond (USA) and entitled ‘The role of
the histamine H4 receptor in allergy and inflammation’.
This was followed by an oral session on Histamine and
CNS and then one on Histamine and Inflammatory
Responses. The planned plenary lecture by Igor Guskin
(Russia) had to be cancelled, again due to the weather
conditions preventing him flying into Sochi. After lunch we
had a coach excursion to the historical Stalin’s dacha. Here
we learnt about Stalin and aspects of his life, including his
love of billiards! Whilst we were at the Zelenaya Roscha
house, a Round Table session on the ‘H1 verses H4
receptor—what is important in allergy?’ in was held in the
meeting room. Delegates representing different fields of
histamine research and chaired by Madeleine Ennis (UK)
produced a lively debate about this new receptor and its
role(s) in the body. In the evening there was more music
and vodka tasting.
We had an early start on Saturday and were taken by
coach through the lush Russian countryside up into the
Caucasian mountains. We stopped to admire the views
and saw the building of the Winter Olympic centre. At
the newly built hospital for the Olympic Games we
listen to the final plenary lecture given by our Treasurer,
Patrizio Blandina (Italy) on ‘Is brain histamine involved
in depression?’ The meeting organisers were very
grateful to Patrizio for undertaking this lecture at short
notice as the planned lecturer from Canada had cancelled
at the last minute. We had a delightful lunch of grilled
trout at the largest trout farm in Europe before heading
back to our hotel. This time we were in a different
venue in the hotel and it was much lighter. However, we
were only to discover that the electricity had been cut
only a short time before we needed it. Eventually we
were able to listen to our students give their presenta-
tions for the Young Investigators Award. Regrettably one
had to withdraw at the last minute due to a family ill-
ness. It was another difficult task for the judges (Fred
Pearce, Frank Ahrens and Elena Rivera) in differentiat-
ing between these presentations. In fact, they awarded
joint winners to Tobias Birnkammer (Germany) and
Tommas Ellender (UK) with the others all being highly
commended. Then we held our General Assembly. At
the start of this meeting the death of one of our dear
Honorary Members, Walter Schnuack (Germany) was
reported and we all reflected on his generosity in sup-
plying histaminergic compounds to members of the
society as well as his wonderful character. According to
our statutes, a new treasurer had to be elected and this
was Pertti Paula (Finland) and we thanked the outgoing
one, Patrizio Blandini (Italy) for his excellent work over
the last 9 years. Our meeting ended with its traditional
excellent Farewell Dinner followed by our award cere-
mony. The certificates and prizes were given out, the
Black Sea Jazz band played for us again and Roman was
often on the piano. Then as usual we had our singing
session, beginning with ‘‘Anita’s Thank You Song’’
(sung to the tune of This Ole House) as thanks to
Roman and his team for the excellent meeting, and then
we sung our EHRS Anthem.
We all agreed that the Russian team, especially Roman,
had worked wonders in keeping the meeting running
smoothly. It was a meeting of some unexpected events but
with excellent science. Our thanks were given to all the
Russians. The next meeting will be held in Belfast,
Northern Ireland (2–5 May, 2012) at the kind invitation of
Madeleine Ennis of Queens University Belfast—please see
http://www.qub.ac.uk/EHRS2012 for more information
about this meeting. This will be a joint meeting with the





Our dear friend, scientific colleague, and Honorary Mem-
ber of the European Histamine Research Society Walter
Schunack died in Berlin, Germany, on April 6, 2011, at the
age of 76 after a short ordeal with an unexpected illness.
Prof. Dr. rer. nat. Dr. med. Dr. h.c. Walter Schunack has
been one of the shining lights in medicinal chemistry for
the design and the synthesis of new ligands for histamine
receptor subtypes. The compounds he developed are used
worldwide for the characterization of the pharmacological
effects of histamine and its receptor subtypes.
Walter Schunack studied pharmacy and medicine in
Mainz, Germany, made his PhD and MD, and started with
the synthesis of histamine derivatives which have been also
tested by him in a new pharmacological set-up at that time.
In 1971 he went to the Freie Universität Berlin, Germany,
as full professor and faithfully stayed there despite some
possibilities for a change. He was passionately involved in
the teaching of numerous generations of students and the
advanced education for pharmacists and physicians in
Germany. During his time he established ‘‘clinical phar-
macy’’ as a new field for pharmacists.
In his research work he has largely been influenced by
the works of E.J. Ariëns and Sir James Black on the
characterization of physiological and pathophysiological
effects of chemical mediators. Taking histamine as his
starting molecule he has been able to develop numerous
novel ligands with high affinity, high selectivity, and dif-
ferent pharmacological behaviour. (R)-alpha-Methyl-
histamine has been one of his major breakthrough findings
for the classical pharmacological characterization of the
histamine H3 receptor subtype. Prodrugs such as BP2.94
were taken in development into clinical phase II. He
developed the histamine H3 receptor antagonist, pitolisant
in collaboration with J.-C. Schwartz, J.-M. Arrang,
M. Garbarg, C. R. Ganellin, J.-S. Lin, and H. Stark, and
this has reached a new medical entity for the therapy of
narcolepsy and excessive daytime sleepiness in Parkinson
patients (late clinical phase III). Unfortunately, he will not
be able to follow further the progress of this compound.
Walter Schunack has been a key player in the field of
ligands for histamine receptors as he has also been
involved in the development of histamine H1 receptor
agonists (e.g. histaprodifen), radio-labeled antagonists for
the histamine H2 receptor (e.g. [
125I]iodoaminopotenti-
dine), several reference ligands for the H3 receptor (e.g.
ciproxyfan, [125I]iodoproxyfan), and specially designed
hybrid compounds. With the recent cloning of the human
histamine H3 receptor he designed one of the first series of
the nowadays mainly used non-imidazole ligands as a
robust pharmacophore element. Although his work in the
histamine area is best known to the scientific community he
also investigated other neurotransmitters and G proteins.
He has received many national and international dis-
tinctions which have recently been mentioned with the
election as Honorary Member of the European Histamine
Research Society 2007 in Florence [1]. Walter Schunack is
also Honorary Member of the Polish Histamine Research
Society (2006), received the Distinguished Service Cross 1.
Class of the Federal Republic of Germany (2002) and a
third doctoral degree honoris causa by Univerité René
Descartes, Sorbonne V, Paris (1998).
As a researcher and empathic personality he has been an
extraordinary talented chemist and teacher, emphasized the
clarity of scientific results and the passion for research. He
has left an enduring imprint on histamine research. We
leave Walter Schunack with great sadness, with even
greater admiration and affection, and with the sincerest of
condolence to his beloved wife and his devoted family.
Reference
1. Black J, Leurs R, Stark H, Sturman G. Honorary
Membership of the European Histamine Research Soci-
ety (EHRS). Inflamm Res. 2008;57(Suppl 1):S03–4.
Institut für Pharmazeutische Chemie, Johann Wolfgang
Goethe University, NeFF/OSF/ZAFES/CMP, Max-von-




EHRS Anniversary Lecture—Birth of the Histamine Club
W. Lorenz
This year we celebrate the 40th anniversary of our
society and I was asked to reflect on the start of the
Histamine Club and who was involved. Unfortunately,
there are only a few of us left who were members of the
Histamine Club but as I am an Honorary Member of
the EHRS I have been given the honour of talking about
the birth of our society. I will attempt to do my very
best—similar to the annual efforts on New Year’s Eve of
the butler James in the famous comedy ‘‘Dinner for
One’’.
Probably the starting point was a Ciba Foundation
Symposium on Histamine in 1955 (published in 1956)
(Fig. 1). I received the Proceedings of this Symposium
from Eugen Werle (my first tutor on the biochemistry of
histamine) who participated in this meeting. It was
dedicated to Sir Henry Dale and combined all the most
influential histaminologists at that time. These included
Feldberg, West, Gaddum, Riley, Sir Henry Dale, Rocha
e Silva, Schild, Schayer, Code, Euler, Kahlson, Paton,
Gregory, Zeller, Werle, Parrot, Halpern and Laborde as
well as many others. It is interesting to note that at the
end of the preface of the proceedings it reads—
‘‘Research on Histamine seems to be at a point at which
important advances can be anticipated’’. Also, last sen-
tence of the General Discussion mentions the existence
of a Histamine Club whose aim was to bring scientists
working on histamine together. Thus this Ciba Founda-
tion brought about the birth of the Histamine Club.
However the entry to this Club was made very presti-
gious as you needed two guarantors from the group of
club members to be introduced. In 1969 I myself became
a member of the Histamine Club and my guarantors
were Czeslaw Maslinski (Poland) and my professor and
tutor Eugen Werle (Germany). At the same meeting
Jean-Charles Schwartz (France) became a member of this
Club.
Fig. 1 The Ciba Foundation Symposium on Histamine (1956)
The main advantage of the Histamine Club was to act as
a forum to bring histaminologists together. In 1971 this
became even more evident at the International Congress of
Physiology in Munich and its Satellite Symposium on
Histamine which was held in Lodz, Poland (Fig. 2).




At that time, Poland was part of the Eastern block countries
and food was restricted. However, Czeslaw Maslinski found
the classical Polish solution: vodka, sardines, sausages, bread
and tomatoes—all from private sources! We also had time for
an excursion on the River Wartha (Fig. 3). During that
meeting I am sure that we never became completely sober but
I still can recall the fantastic atmosphere. This was the first
informal meeting of the Histamine Club which paved the way
to our Histamine Society, and Jean-Louis Parrot was our
General Secretary, a role which he retained until 1974.
Fig. 3 Our Histamine Club excursion on the River Wartha, Poland
with Jean-Louis Parrot, our first General Secretary in the centre
Jean-Louis edited the annual Histamine Bulletin which
contained a collection of abstracts from many papers on
histamine in journals of various scientific societies, and
managed the network of the Histamine Club. He was also
Professor of Physiology at the Necker-Institute in Paris and
a member of the Académie Française. In Lodz it was
suggested that we have a General Assembly at our future
meetings and after hefty debate this was accepted. This
meeting was a considerable success—somewhat expected
and somewhat sensational, but we were not able to rec-
ognize its significance immediately.
Jean-Charles Schwartz proposed Paris for the venue for
the first official meeting of the Histamine Club in 1972
with Marburg for the following year (1973) and Copen-
hagen the next (1974). The Paris meeting ended with an
excellent dinner in Jean-Charles’ home hosted by his wife
Kitty and the abstracts published in the French Journal of
Pharmacology, Vol. 3 (1972). In 1974 Jean-Louis Parrot,
who had done a great job as General Secretary handed over
this role to Geoffrey West (UK). However, over the next
few years it was felt necessary to change the established
Club into a new scientific society. The Histamine Club
became the European Histamine Research Society (EHRS)
in 1979 but it still kept the ‘family atmosphere’ and
encouraged members to help each other to solve histaminic
problems. During Geoff’s time the society drew up rules
and regulations and also started to award poster prizes.
In 1972 there was a significant step in histamine
research—the discovery of a histamine H2 antagonist,
burimamide by Black and co-workers. Jim Black, who
previously was not known within the Histamine Club,
made an immediate impact on all of us with his warm
personality and excellent science. The clinical study of the
new discovery using metiamide was rejected by The Lan-
cet and so Jim Black published the randomized clinical
trial results on metiamide in our newly founded journal
Agents and Actions. This work led to the development of
the clinically extremely successful cimetidine.
Black J. W., Duncan W. A. M., Emmett J. C. (1973)
Metiamide – an orally active histamine H2-receptor
antagonist. Agents and Actions 3, 133–137.
Since then two more histamine receptors have been
discovered; the H3 and the H4.
Fig. 4 Jim Black and Piero Mannaioni at one of our meetings
For 25 years, I was the editor for Agents and Actions,
which was renamed in 1995 as Inflammation Research
because several other international societies wished to also
publish their meetings in the journal.
In 1988, Piero Mannaioni (Italy) (Fig. 4) became our
General Secretary/President and now we are proud of our
two lady EHRS presidents; Madeleine Ennis (UK), who
had worked with Pearce and Lorenz (1999–2006) and
Anita Sydbom (Sweden), who had trained under Uvnäs, the
former Chair of the Nobel Committee and first President of
the International Union of Pharmacology (IUPHAR)
(2006–to date).
Last year we lost our dear Honorary Member, the
Nobel Laureate Sir James Black (UK) whose achieve-
ments included being the senior author on the first paper
on the H2 antagonist (Nature 1972) and this year Walter
Schunack (Germany) but the society does not stand still.
The most remarkable feature of the EHRS is the strong
friendship and close cooperation between participants
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which has led to the development of European Research
Groups resulting in important discoveries. For example,
the development of reliable histamine assays and model
systems (Uvnäs, Lorenz, Pearce) provided clear evidence
for the clinical relevance of histamine and the synthesis
of histamine agonists and antagonists (Schwartz, Gann-
elin, Schunack) provided the tools for our further
research. The EHRS is still attracting more new mem-
bers, especially young histaminologists, plus the science
is excellent!




40 years EHRS—science, fun and friends in Europe
M. Ennis
Unofficially the EHRS started with a meeting in Lodz,
Poland in 1971, followed by the official establishment of
the European Histamine Club in Paris in 1972. Geoff
West (UK) became the Secretary General in 1974. In
1979, we became the European Histamine Research
Society (EHRS) during our first ever meeting on a boat!
This enabled one of our more forthright chairmen to
declare that any speakers going over their allotted time
would be thrown overboard! Piero Mannaioni (Italy)
took over the reins in 1988, followed by me in 1999.
However, I changed the title to President! Anita Sydbom
(Sweden) became our President in 2006. She also per-
forms a very interesting duty for the society, it started
off as a one off in 1988 but now she has to write a
special song for the meeting every year!
Meetings traditionally run for 3 days—well they actu-
ally start the night before and go on till breakfast on the
final day, so really Wednesday to Sunday! We avoid par-
allel sessions as much as possible, so everybody stays to
listen to all aspects of the subject. This can lead to some
very interesting and thought provoking questions. We have
an outing lasting an afternoon and evening and we often eat
lunch en route! Essentially we spend all the time toge-
ther—which results in many fruitful scientific collaborative
projects as well as good friendships. The society has seen
the growth of the Histamine field from 1 receptor to 4;
resulting in many new areas for research. No longer just
important in allergy but histamine plays a role in memory,
obesity, ulcers, cancer etc.
Our idea of Europe is one that defies traditional
boundaries so we have dedicated members from Japan,
China, Korea, the Americas etc. It is a very friendly soci-
ety, small enough so that you can speak to everybody and
where young scientists are not afraid to go up to more
senior colleagues and ask questions. Many even regard it as
family! So as all families do, we miss those who are no
longer with us, we benefited greatly from their wisdom.
Long may the EHRS survive and thrive.









THE ROLE OF THE HISTAMINE H4 RECEPTOR
IN ALLERGY AND INFLAMMATION
R.L. Thurmond
Histamine is known to be one of the key mediators of
allergic inflammatory conditions. However, evidence is
now accumulating to suggest that histamine has a role in
inflammation beyond that traditionally described for acute
allergic symptoms. The discovery of a fourth histamine
receptor (H4R) 10 years ago and its expression on a num-
ber of immune/inflammatory cells has prompted the
re-evaluation of the actions of histamine. The H4 receptor
mediates chemotaxis and cytokine release of mast cells,
eosinophils, monocytes, dendritic cells and T cells. In
addition, histamine released from mast cells or from other
cell types can influence T cell polarization via activation of
the H4R. The receptor also mediates T cell activity in vivo
and has a proinflammatory effect in models of the innate
immune response like peritonitis or colitis models, but also
in models of asthma and contact dermatitis, where it
mainly effect T cell responses. These data suggest that the
H4 receptor is attractive target for the treatment of
inflammation, allergy and asthma. The recent data on the
novel functions of the H4R have opened an exciting new
chapter in the already impressive history of histamine
research and should lead to new understanding and,
hopefully, breakthrough therapies for the treatment of
allergic disease.
Johnson & Johnson Pharmaceutical Research &
Development, L.L.C., San Diego, CA 9212, USA. E-mail:
rthurmon@its.jnj.com
JNJ-39220675, A NOVEL SELECTIVE
HISTAMINE H3 RECEPTOR ANTAGONIST,
REDUCES THE ABUSE-RELATED EFFECTS
OF ALCOHOL IN RATS
R. Galici, A.H. Rezvani, L. Aluisio, B. Lord, E.D. Levin,
I. Fraser, J. Boggs, N. Welty, J.R. Shoblock, S.T. Motley,
M.A. Letavic, N.I. Carruthers, C. Dugovic, T.W. Lovenberg,
P. Bonaventure
Recent studies suggest that brain histamine levels and
signalling via H3 receptors play an important role in
modulation of alcohol stimulation and reward in rodents.
The present study characterized the effects of a novel,
selective and brain penetrant H3 receptor antagonist (JNJ-
39220675) on the reinforcing effects of alcohol in rats.
The effect of JNJ-39220675 on alcohol intake and
alcohol relapse-like behaviour was evaluated in selectively-
bred alcohol-preferring rats using the standard two-bottle
choice method. The compound was also tested on operant
alcohol self administration in non-dependent rats and on
alcohol-induced ataxia using the rotarod apparatus. In
addition, alcohol-induced dopamine release in the nucleus
accumbens was tested in freely moving rats.
Subcutaneous administration of the selective H3 recep-
tor antagonist dose-dependently reduced both alcohol
intake and preference in alcohol preferring rats. JNJ-
39220675 also reduced alcohol preference in the same
strain of rats following a 3-day alcohol deprivation. The
compound significantly and dose-dependently reduced
alcohol self-administration without changing saccharin
self-administration in alcohol non-dependent rats. Fur-
thermore, the compound did not change the ataxic effects
of alcohol, alcohol elimination rate nor alcohol-induced
dopamine release in nucleus accumbens.
These results indicate that blockade of H3 receptor
should be considered as a new attractive mechanism for the
treatment of alcoholism.
Johnson & Johnson Pharmaceutical Research &
Development L.L.C., 3210 Merryfield Row, San Diego, CA
92121, USA. E-mail: ncarruth@prdus.jnj.com
MODULATION BY HISTAMINE H3
RECEPTORS OF GLUTAMATERGIC
TRANSMISSION IN RAT GLOBUS PALLIDUS
A. Osorio-Espinoza, A. Alatorre, J. Ramos-Jiménez,
B. Garduño-Torres, M. Garcı́a-Ramı́rez, E. Querejeta,
J.-A. Arias-Montaño
The globus pallidus (GP), involved in the control of motor
behavior, expresses high levels of histamine H3 receptors
(H3Rs) and the virtual absence of the corresponding mRNA
strongly suggests they are located on nerve terminals as
auto- and hetero-receptors. The main synaptic afferents to
the GP originate in the striatum (GABAergic), substantia
nigra pars compacta (dopaminergic), subthalamic nucleus
and cerebral cortex (glutamatergic). Here we studied the
effect of the activation of rat pallidal H3Rs on depolar-
ization-evoked neurotransmitter release from slices,
neuronal firing rate in vivo and turning behavior. Perfusion
of GP slices with the selective H3R agonist immepip had
no effect on [3H]-GABA or [3H]-dopamine release evoked
by high (20 mM) K+, but significantly reduced [3H]-
D-aspartate release (-44.8 ± 2.6%, n = 6, and -63.7 ±
6.2%, n = 3, at 30 and 100 nM, respectively; P \ 0.05,
ANOVA and Student–Newman–Keuls test). The effect of
30 nM immepip was blocked by 10 lM of the selective
H3R antagonist A-331440 (n = 5). Intra-pallidal injection
of immepip (0.1 ll, 100 lM) decreased spontaneous
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neuronal firing rate in anaesthetized rats (peak inhibition
68.8 ± 10.3%, n = 13, P \ 0.05) and this effect was
reversed in a partial and transitory manner by A-331440
(0.1 ll, 1 mM, n = 4). In free-moving rats the intra-pal-
lidal infusion of immepip (0.5 ll; 10, 50 and 100 lM,
n = 7–9) induced dose-related ipsilateral turning following
systemic apomorphine (0.5 mg/kg, s.c.). Turning behavior
induced by local immepip (0.5 ll, 50 lM) and systemic
apomorphine was partially prevented by local injection of
the antagonist A-331440 (0.5 ll, 1 mM, n = 8) and was
not additive to the turning evoked by the intra-pallidal
injection of antagonists at ionotropic glutamate receptors
(0.5 ll, 1 mM each of AP-5 and CNQX, n = 5–8,
P [ 0.05). These results indicate that pre-synaptic H3Rs
modulate glutamatergic transmission in rat globus pallidus
and thus participate in the control of movement by basal
ganglia.
Departamento de Fisiologı́a, Biofı́sica y Neurociencias,
Centro de Investigación y de Estudios Avanzados del IPN,
07360 México, D.F., México. E-mail: aosorio@fisio.
cinvestav.mx
EFFECT OF HISTAMINE H3 RECEPTOR
ACTIVATION ON NEUROTRANSMITTER
RELEASE FROM SLICES OF THE RAT
OLFACTORY BULB
G. Aquino-Miranda, A. Osorio-Espinoza, J. Escamilla,
J.-A. Arias-Montaño
The olfactory bulb is the first relay station of the central
olfactory system in the mammalian brain. The rat olfactory
bulb (rOB) possesses moderate histaminergic innervation but
a very high density of histamine H3 receptors (H3Rs). H3Rs are
primarily hetero-receptors that control pre-synaptically the
release of several neurotransmitters. Here we studied the
effect of H3R activation on the depolarization-evoked release
of labeled neurotransmitters ([3H]-GABA, [3H]-D-aspartate,
[3H]-noradrenaline and [3H]-dopamine) from rOB slices. The
presence of pre-synaptic H3Rs was confirmed by the specific
binding of N-a-[methyl-3H]histamine ([3H]-NMHA) to
membranes from rOB synaptosomes (maximum binding,
Bmax, 106 ± 19 fmol/mg protein and dissociation constant,
Kd, 0.68 ± 0.11 nM, n = 4). [
3H]-NMHA binding was
inhibited by the H3R agonists immepip (pKi 9.49 ± 0.13) and
R-a-methylhistamine (RAMH, pKi 9.10 ± 0.04) as well as by
the H3R antagonist clobenpropit (pKi 8.83 ± 0.07; n = 3).
Perfusion of labeled rOB slices with the selective H3R agonist
RAMH (1 lM) had no effect on the release of [3H]-GABA,
[3H]-D-aspartate or [3H]-dopamine evoked by depolarization
with high (20 mM) K+, but reduced [3H]-noradrenaline
release in a modest although significant manner (83.1 ± 2.1%
of control release, n = 3, P \ 0.05, ANOVA and Tukey test).
The inhibitory effect of RAMH (1 lM) on K+-evoked [3H]-
noradrenaline release was blocked by the selective H3R
antagonist/inverse agonist clobenpropit (5 lM; n = 3). When
tested alone clobenpropit and a second H3R antagonist/inverse
agonist, ciproxifan (both at 1 lM), increased K+-induced
[3H]-noradrenaline release in a modest but significant manner
(121.9 ± 5.9 and 117.0 ± 3.2% of K+ alone, respectively,
n = 3–4, P \ 0.05). These results indicate that: (1) pre-syn-
aptic H3Rs do not regulate GABA, glutamate or dopamine
release in rOB, (2) noradrenaline release in rOB is modulated
by pre-synaptic H3Rs with constitutive activity.
Departamento de Fisiologı́a, Biofı́sica y Neurociencias,
Centro de Investigación y de Estudios Avanzados del
IPN, 07360 México, D.F., México. E-mail: aosorio@fisio.
cinvestav.mx
THE ROLE OF THE HISTAMINE H4 RECEPTOR
ON HUMAN INVARIANT NATURAL KILLER
T CELL SUBTYPE
S. Mommert, M. Gschwandtner, G. Köther, R. Gutzmer,
T. Werfel
A functional role of the histamine H4 receptor (H4R) on the
three main types of CD4+ T cells—Th1, Th2 and Th17
cells—has been described recently. Invariant natural killer T
cells (iNKT cells) constitute the majority of unconventional
or innate like T cells in the skin. Most recently iNKT cells
were detected among infiltrating T lymphocytes in the
lesional skin of atopic eczema and other inflammatory skin
diseases in which they are exposed to histamine, raising the
question whether histamine can regulate iNKT cell function.
Human iNKT cells are typified by a conserved
invariant Va24Ja18 T cell receptor chain paired with a
Vb11 chain and by their ability to recognize bacterial
glycolipids and rapid production of several cytokines
(e.g. IL-4 and IFN-c). To investigate the influence of
histamine especially via the H4R on this rare subtype of T
lymphocytes we first enriched these cells. To do this, we
expanded iNKT cells in PBMCs using the glycolipid
aGalactocylceramide and isolated the Va24Ja18+ and
CD3+ cells by fluorescence-activated cell sorting. The
expression of the H4R was evaluated by real-time PCR
and by flow cytometry.
We could show for the first time the expression of the
H4R at the mRNA and protein level on human iNKT cells.
To evaluate if the stimulation of human iNKT cells with
selective H4R agonists triggers the secretion of multiple
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cytokines and cytotoxic molecules, we applied real-time
PCR, flow cytometry and enzyme linked immunosorbent
assay. We found no evidence for IL-4 and IFN-c regulation
in response to histamine and H4R agonists. This is in
contrast to recent published data on murine iNKT cells.
Preliminary results show a possible effect of histamine via
H4R on IL-22 regulation which requires further
experiments.
Division of Immunodermatology and Allergy Research,
Hannover, Department of Dermatology and Allergy, Han-
nover Medical School, Hannover, Germany. E-mail:
mommert.susanne@mh-hannover.de
EFFECT OF HISTAMINE ON HUMAN
NEUTROPHILS
M. Ennis, V. Brown, K. Dib
Recent data have shown that the histamine H4 receptor
(H4R) is involved in chemotaxis of inflammatory cells such
as eosinophils and neutrophils in asthmatic animal models.
During episodes of allergic inflammation, chemoattractants
guide neutrophils to the airways by switching b2 integrins
from a low affinity to a high affinity ligand binding confor-
mation, thus allowing these adhesion receptors to bind
endothelial ligands. This is a prerequisite for firm adhesion to
the endothelium, migration to the site of allergic inflamma-
tion, and activation of b2 integrin-dependent inflammatory
functions (respiratory burst, degranulation). The aim of this
study was to examine the effects of histamine on b2 integrin
function and neutrophil degranulation.
By flow cytometry, we showed that in resting neutro-
phils from healthy controls, around 1% of the cells express
b2 integrins in a high affinity ligand binding conformation.
This percentage raised up to 55% in cells that had been
stimulated with fMLP (0.1 mM), a potent chemoattractant,
and up to 13.5% in neutrophils stimulated with histamine
(10-7–10-6 M). Surprisingly, despite the fact that hista-
mine induced activation of b2 integrins, the vasoamine
blocked b2 integrin-dependent degranulation. Indeed,
incubation of human neutrophils with histamine (10-8–
10-6 M) blunted the release of lactoferrin (a marker of
specific granules) in the extracellular milieu, induced by
fMLP, or engagement of b2 integrins. We also found, by
flow cytometry, that human peripheral neutrophils, in
addition to H1R and H2R, express also the H4R.
We concluded that histamine may control b2 integrin-
dependent migration of human neutrophils via the H4R
whereas the vasoamine may control, in an inhibitory
manner, inflammatory functions of neutrophils (degranu-
lation) via H1R or/and H2R. This could be important in
diseases such as severe neutrophilic asthma and COPD.
Supported by COST Action BM0806.
The Queen’s University of Belfast, Belfast BT9 7BL, UK.
E-mail: M.ennis@qub.ac.uk
PREVENTION OF BLEOMYCIN-INDUCED
PULMONARY FIBROSIS BY A SELECTIVE
HISTAMINE H4R ANTAGONIST
A. Pini, T. Somma, G. Formicola, R.T. Thurmond,
D. Bani, E. Masini
Pulmonary fibrosis is a progressive and lethal lung disease
characterized by lung inflammation and abnormal remod-
eling of lung parenchyma. At the moment no cure exists for
this disease. The histamine H4R, widely expressed on cell of
immune origin, plays an important role in inflammatory
processes. We previously demonstrated that JNJ7777120
(JNJ), a H4R antagonist, decreases the inflammatory
response in animal models of asthma and carrageenan-
induced pleurisy.
The aim of this study was to investigate the anti-
inflammatory and anti-fibrotic effects of the histamine H4R
antagonist JNJ in a mouse model of bleomycin-induced
pulmonary fibrosis. We also compared the effects of JNJ
with those of naproxen, a classical NSAID. The bleomycin-
induced mice were treated with vehicle or JNJ (total dose
40 mg/kg bw) or equimolar naproxen, released by micro-
osmotic pumps. Airway resistance to inflation, an index of
lung stiffness, was assayed and lung tissue was processed
to evaluate inflammation and fibrosis biochemically and
histologically.
JNJ exerted an anti-inflammatory effect, as shown by a
significant decrease in the levels of PGE2, myeloperoxi-
dase, an index of leukocyte infiltration, and thiobarbituric
acid reactive substances, markers of oxidative stress. JNJ
administration also reduced the relative number of goblet
cells and the thickness of smooth muscle layer, two key
parameters of inflammation-induced adverse bronchial
remodeling. Moreover, treatment with JNJ resulted in a
strong inhibition of lung fibrosis, as shown by the
reduction of the tissue levels of the pro-fibrotic cytokine
TGF-b and of collagen; this was accompanied by a
decrease in airway resistance to inflation. No significant
differences were observed between the JNJ and naproxen
treatment. Our results indicated that JNJ exerted an anti-
inflammatory and anti-fibrotic activity and may offer a
new therapeutic option for the treatment of pulmonary
fibrosis.
Dept. of Preclinical and Clinical Pharmacology, Uni-




THE ROLE OF HISTAMINE RECEPTOR
H3 IN PANCREATIC b-CELLS
T. Nakamura, T. Yoshikawa, N. Noguchi, M. Ohsugi,
K. Yanai
H3 receptor (H3R), a G-protein coupled receptor (GPCR),
is coupled to inhibitory Gi protein and exerts effects on
various biological functions including sleep-awake cycle
and cognition. A number of evidences have showed that H3
receptor modulate hypothalamic neural activities leading to
reduction of food intake and body weight. H3R in central
nervous system (CNS) has become one of the new thera-
peutic targets of obesity. There is, however, no information
related to the role of H3R in peripheral metabolic organs
such as pancreatic b-cells, which are also involved in
energy metabolism as well as CNS. Several GPCRs
expressed in pancreatic b-cells such as glucagon-like
peptide-1 receptor and a2A adrenergic receptor play
important roles in insulin secretion and b-cell proliferation,
whereas the expression and function of H3R in pancreatic
b-cells remain to be elucidated.
First, we found that H3R was predominantly expressed
among histamine receptors in mouse pancreatic b-cells and
MIN6 cells, a cell line derived from mouse pancreatic
b-cells. Next, we examined the effect of H3R on insulin
secretion from MIN6 cells using imetit, an H3R agonist.
Imetit remarkably inhibited glucose-induced insulin
secretion in a dose-dependent manner, while basal insulin
secretion with imetit was preserved. In addition, we
investigated the effect of imetit on the proliferation of
MIN6 cells and found imetit attenuated BrdU incorporation
into MIN6 cells after insulin stimulation, suggesting H3R
decreases b-cell proliferation.
In this study, we have demonstrated for the first time
that H3R was expressed in mouse pancreatic b-cells and
H3R activation with imetit significantly inhibited insulin
secretion and b-cell proliferation. These results indicate
that H3R may play an essential role in b-cell functions and
be an eligible therapeutic target of diabetes in obese
patients.
Department of Pharmacology, Tohoku University
Graduate School of Medicine, Sendai, Japan. E-mail:
yanai@med.tohoku.ac.jp
ANTIHISTAMINE DRUG, DIMEBON, WITH
MULTIPLE MECHANISMS OF ACTIONS
R. Khanferyan, O. Chekanova, J. Dorofeeva,
A. Galenko-Jaroshevsky
Synthesized in Russia over 40 years ago and used clinically as
an effective anti-allergic drug from 1983, is the drug Dimebon
(9-/2-(2-methylpyridyl-5) ethyl/3,6-dimethyl-1, 2, 3, 4-tetra-
hydro-gamma-carboline dihydrochloride). In 2008, ‘The
Lancet’ reported on the efficacy of Dimebon in patients with
Alzheimer’s disease with Dimebon. There was a significant
improvement in Alzheimer’s disease compared to placebo
(mean drug-placebo difference -4.0 [95% CI -5.73 to
-2.28]; p \ 0.0001). Besides antihistamine activity, Dime-
bon has many other mechanisms of actions; blocking the
action of neurotoxic b-amyloid proteins, inhibiting L-type
Ca2+ channels, and modulating action of AMPA (a-amino-
3-hydroxy-5-methyl-4-isoxasol-propionic acid) and NMDA
(N-methyl-D-aspartate) glutamate receptor subtypes. Dime-
bon also blocks other receptors, such as a-adrenergic
receptor and several serotonin receptors (5-HT2C, 5-HT5A
and 5-HT6). We have shown in experiments on guinea-pigs
sensitized with ragweed pollen that Dimebon exerts marked
anti-anaphylactic activity which compares with that of
another Russian H1 antagonist, Phencarol. When adminis-
tered in minimal effective doses, Dimebon is less active
than ketotifen, but in doses of 2.5 and 5 mg/kg it is more
effective. Marked anti-anaphylactic activity of Dimebon is
due to its antihistamine and antiserotonin actions. When
administered intragastrically, s.c. and i.v., Dimebon was
less toxic than Phencarol (by 1.28, 1.78 and 1.43-fold,
respectively) and Ketotifen (by 1.78, 1.68 and 5-fold,
respectively). In the rat Dimebon decreases the histamine-
releasing activity of dextran T-70. In a series of experi-
ments using cultivated PBMC from healthy donors in the
presence of Dimebon, the H3/H4 antagonist imoproxifan
was more effective in the modulating IgE response than
other drugs. We are proposing that the antiallergic and CNS
effects of Dimebon may be due to the antagonism of H3/H4
subtypes of histamine receptor.
Kuban State Medical University, Sedin str., 4. Krasno-









IS BRAIN HISTAMINE INVOLVED
IN DEPRESSION?
L. Munari, G. Provensi, M.B. Passani, N. Galeotti,
T. Cassano, P. Blandina
Mice unable to synthesize histamine, due to targeted disruption
of histidine decarboxylase (HDC) gene or i.c.v. injection of
alpha-fluoromethylhistidine (a-FMH, 5 lg), a suicide inhibitor
of HDC, were used to test roles for histamine in mediating
behavioural changes elicited by different classes of antide-
pressants, selective serotonin reuptake inhibitors (SSRI) such
as citalopram and paroxetine or selective noradrenaline reup-
take inhibitors (SNRI), such as reboxetine. The tail suspension
test (TST) which is a widely used paradigm for assessing
antidepressant activity was used. Both classes of antidepres-
sants reduced immobility in controls [wild type (WT) mice for
HDC-KO mice, and saline-injected CD-1 mice for a-FMH-
treated CD-1 mice (n = 11–18)]. HDC-KO mice as well as
a-FMH-treated CD-1 mice failed to respond to acute injections
of citalopram (10 mg/kg, i.p.) or paroxetine (10 mg/kg, i.p.)
with a reduction of immobility. Conversely, reboxetine (5 mg/
kg, i.p.) reduced immobility in both WT and HDC-KO mice
(p \0.0001). Since the histaminergic tuberomammillary
nucleus receives 5-HT inputs from the raphé, we investigated
whether SSRIs affect histamine release. CD-1 male mice
(*30 g) were implanted with a microdialysis probe in the pre-
frontal cortex. After 48 h recovery, the probe was perfused with
Ringer’s solution (1 ll/min) and dialysates were collected
every 30 min. Histamine was detected by HPLC-fluorometric
detection. Spontaneous histamine release was 0.058 ±
0.006 pmol/30 min (n = 6). Citalopram (10 mg/kg; i.p.)
increased HA up to more than 50% of basal value. 5-HT
transmission appears intact in HDC-KO mice, since local
infusion of citalopram (50 lM) into the hippocampus of HDC-
KO mice increased by more than 100% the basal release of
5-HT, as measured by microdialysis. These data show that the
central histamine system plays an important role in mediating
acute behavioural and neurochemical actions of citalopram.
Dipartimento di Farmacologia Preclinica e Clinica,
Universitá di Firenze, 50139 Firenze, Italy. E-mail: patrizio.
blandina@unifi.it
CORRELATION OF PSYCHOTIC SYMPTOMS
WITH CHANGES IN GLOBUS PALLIDUS H3
RECEPTORS IN MAJOR HUMAN DEMENTIAS
N.L. Lethbridge, P.L. Chazot
Alzheimer’s disease (AD) and Dementia with Lewy bodies
(DLB) represent the two most common human dementias,
each which display variable degrees of psychosis
symptoms, which are difficult to treat with current thera-
pies. In this study, we determined the levels of H3
histamine receptors (H3Rs), using [
3H] GSK189254 auto-
radiography and post-mortem tissue from a cohort of
validated AD and DLB cases (Newcastle Brain bank, UK).
Whereas many other brain structures remained
unchanged, the globus pallidus H3Rs displayed a range of
changes in AD and DLB cases in comparison to control
cases. Differential bidirectional changes in [3H]
GSK189254 binding levels were observed in male AD (no
change), DLB (decrease) and control cases (increase to
level seen in AD cases); in contrast female AD and DLB
cases remained constant (n = 3–4 individual cases).
These cases were further analysed to assess whether
presence of delusions and visual hallucinations correlated
with changes in globus pallidus H3Rs. Overall, the psy-
chotic positive symptoms assessed (delusions and visual
hallucinations) did not correlate for a range of cortical and
basal ganglia structures, with the exception of the globus
pallidus. DLB cases with moderate to high delusion and
visual hallucination scores displayed approx. 40% higher
[3H] GSK189254 binding levels (n = 6–7 individual
cases), in comparison to cases lacking such psychotic
symptoms. There was a trend for a similar correlation for
AD cases. The volume of the human globus pallidus has
been previously positively correlated with the severity of
global psychotic symptoms, as measured by both the Scale
for the Assessment of Negative Symptoms and Positive
Symptoms, which may account for this apparent increase in
H3 receptors.
This provides further evidence for the potential use of
H3R antagonists in treating the psychotic symptoms in
schizophrenia and, perhaps, Lewy body dementias.
NL was supported by a BBSRC GSK CASE award
School of Biological & Biomedical Sciences, Durham
University, UK. E-mail: paul.chazot@durham.ac.uk
THE HISTAMINE H3 RECEPTOR HAS
A LIMITED ROLE TO PLAY IN ANXIETY
BEHAVIOUR
P.L. Chazot, N.L. Lethbridge, A. Ennaceur
Our new developed and patented open space test system for
measuring anxiety responses has been validated with dif-
ferent strains of mice (e.g. Balb/c high anxiety and CD-1
low anxiety strain). It has been shown to be sensitive to a
standard clinical anxiolytic agent. This represents the first
behavioural test which can discriminate anxiety and
hyperactivity responses, and can be used in multiple ses-
sions for assessment of chronic treatments. In this study,
2 month old Balb/c mice were divided into four groups
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(8 animals per group) and received either saline, or a H3R
antagonist GSK334429B at 0.1, 0.3 or 1 mg/kg i.p. (sup-
plied by Dr AD Medhurst, GSK) and then exposed to the
open space test (elevated configuration). This behavioural
paradigm simultaneously examined emotional responses to
novelty and open spaces and motor activity over 5 daily
12 min. sessions. Motor activity and anxiety measures for a
mouse on the open space behavioural paradigm consisted
of the number of crossings in the surface of the platform,
latency of the first entry, number of entries and duration of
entries onto the stands, respectively. An increase in number
of crossings onto the stands, increased time spent on
stands, and a reduction in the latency of first entry to the
stand simultaneously would reflect a lower level of anxiety
(an anxiolytic agent). There were no significant differences
between any of the 4 groups indicating that GSK334429B
is neither anxiolytic nor anxiogenic. Majority of results
were statistically insignificant, but there was significance
between sessions. This was to be expected, as the more
exposed the mice are to the test they would begin to
overcome the anxiety of the novelty and open space
environment.
This study provided new evidence that that the H3 his-
tamine receptor, while it may be involved in fear-
avoidance responses, it is not implicated in anxiety
responses. This concurs with other unpublished studies
from our laboratory using the 3D maze open space anxiety
test, together with both selective H3 agonist and antagonist
drugs.
NL was supported by a BBSRC GSK CASE award.
School of Biological & Biomedical Sciences, Durham
University, UK. E-mail: paul.chazot@durham.ac.uk
FORMAL IDENTIFICATION OF HUMAN
NATIVE H3 RECEPTOR (H3R) ISOFORM
PROTEINS AND POTENTIAL DIFFERENTIAL
CHANGES IN H3R ISOFORMS IN MAJOR
LEWY BODY DISEASES
N.L. Lethbridge, P. Chazot
We have developed and characterised a selection of novel
isoform selective human H3R probes: anti-H3R PAN
antibody, anti-hH3R445/453 antibody, anti-hH3R365/445, anti-
hH3R329 antibody and anti-hH3R200 antibodies. Selectivi-
ties were confirmed utilising respective cDNAs expressed
in HEK 293 cells and probed by comparative quantitative
immunoblotting. Herein, these probes were used to identify
for the first time, human H3R isoform proteins expressed
in vivo in human putamen, and to determine using quan-
titative immunoblotting (n = 3–4 individual samples per
group), whether there were any changes in expression of
H3R isoforms in human Lewy body disease.
There were no significant difference in immunoreac-
tivities between the two disease states and control samples,
indicating that the full length hH3R445/453 expression is
unaltered in Parkinsons Disease (PD) and Dementia with
Lewy Bodies (DLB) compared with control cases. There
were no significant differences in immunoreactive signals
detected with the anti-hH3R365/445 antibody between the
two disease states, with the exception of the putative H3R
365 isoform, where there was a significantly stronger
immunoreactivity signal in DLB, but not in PD, versus
control cases. In contrast, there was a significant increase in
anti-hH3R329 immunoreactivity in the PD cases compared
to both control and DLB cases.
These results suggest that H3R 365 and H3R 329 isoform
expression maybe up-regulated and down-regulated in
DLB and PD, respectively, while H3R 445 isoform remains
largely unchanged in both Lewy body dementias.
NL was supported by a BBSRC GSK CASE award.
School of Biological & Biomedical Sciences, Durham
University, Durham, UK. E-mail: paul.chazot@durham.
ac.uk
EFFECTS OF MONOAMINE SYSTEM
DIRECTED MULTITARGET DRUG ON RAT
BRAIN AMINE TRANSMITTERS AND ON
COGNITIVE FUNCTIONS IN RAT MODEL
OF VASCULAR DEMENTIA
A. Stasiak, M. Mussur, M. Unzeta, A. Samadi,
J.L. Marco, W.A. Fogel
Deficits in amine neurotransmitters are seen in neurode-
generative diseases and currently the idea is to use multi-
target drug treatment. ASS234, a novel compound in vitro
suppressing MAOA and B, and AChE/BChE activities, was
examined for its effect on deteriorated memory in Wistar
rats with post bilateral common carotid artery occlusion
(BCCAO). The drug was given daily (5 mg/kg, s.c.) for
5 days to intact or 1 day post BCCAO surgery. Working
and reference memory was evaluated using hole-board
tests; before and 7 and 12 days after BCCAO. Enzyme
activities MAOs and histamine N-methyltransferase were
measured by radioassays and acetylcholinesterase with an
AChE fluorescent kit. Amine concentrations analysed with
RIA kits (5HT, DA, NA), radioenzymatically or fluori-
metrically (histamine) and by GC/MS (t-methylhistamine).
In the brain, ASS234 treatment resulted in 60% inhibition
of MAO B activity and undetectable MAO A. However,
5HT concentration increased [3 times, dopamine and
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noradrenaline [ twice. The histamine system was less
affected: histamine and t-methylhistamine levels increased
by *30% and there was a small decrease in HMT activity
(40 ± 0.7 vs. 44 ± 1.1 pmol/min/mg protein, p \ 0.05);
the last could be a direct effect of ASS234 on HMT or
substrate inhibition (methylhistamine). AChE activity as
measured in striatum, decreased insignificantly. However,
AChE has a very high turnover rate and the drug was only
given once a day. Food and water intake and urine pro-
duction were all decreased. This could be facilitated by
brain 5HT increase but histamine involvement cannot be
excluded. Interestingly the ASS234 treated BCCAO rats
showed less negative effects of cerebral hypoperfusion
(BCCAO) on behavioural memory parameters. Thus the
amine system, due to complicated interplays, should be
targeted as a whole entity.
Supported by the Grant No 178/N-COST/2008/0 from
Ministry of Science and Higher Education, Warsaw,
Poland. COST Action D34 is acknowledged.
Dept. of Hormone Biochemistry, Medical University of
Lodz, 90-752 Lodz, Poland. E-mail: wieslawa.agnieszka.
fogel@umed.lodz.pl
DIFFERENTIAL CONTROL OF STRIATAL
INHIBITION BY HISTAMINE
T.J. Ellender, I. Huerta-Ocampo, M. Capogna, J.P. Bolam
The striatum receives modulatory input from the hypo-
thalamic histaminergic system. Histaminergic neurons
exhibit a diurnal rhythm in their activity, being active
during day and relatively silent at night. Thus the striatum
is likely to experience a relatively high concentration of
histamine (H) during the day. This, combined with the high
expression of H receptors in the striatum, suggests that H
might have a strong regulatory role in striatal function.
We investigated the role of H in the modulation of the
main excitatory and inhibitory inputs to the principal
neuron of the striatum, the GABAergic medium spiny
projection neurons (MSNs). We performed whole-cell
patch-clamp recordings of single MSNs, pairs of connected
MSNs and pairs of connected interneurons and MSNs. We
investigated the effect of bath-applied H (10 lM) in con-
junction with selective H receptor antagonists on the
excitatory responses evoked by cortical or thalamic stim-
ulation or inhibitory responses evoked by local stimulation
or unitary inhibitory responses between pairs of neurons.
We found that both cortical and thalamic inputs to
MSNs were negatively modulated by bath applied H,
which was prevented by co-application of the H3 receptor
antagonist, thioperamide (10 lM). Similarly, inhibitory
inputs evoked by local stimulation were negatively
modulated by bath applied H. However, in paired
recordings only the unitary inhibitory responses between
pairs of MSNs were significantly reduced, whereas those
between fast spiking interneurons and MSNs were
unaffected.
Thus the histaminergic innervation of the striatum is
involved in the negative regulation of both of the main
excitatory inputs and the feed-back inhibitory input
between MSNs, but does not affect the feed-forward
inhibitory input from the fast spiking interneurons. Selec-
tive attenuation of feed-back inhibition by H will alter the
striatal processing of excitatory inputs and by extension the
expression of basal ganglia behaviour.
This work was supported by the MRC and the European
Community.
MRC Anatomical Neuropharmacology Unit, Dept.
Pharmacology, University of Oxford, OX1 3TH, Oxford,
UK. E-mail: tommas.ellender@pharm.ox.ac.uk
SPECIFIC EFFECTS OF CENTRAL H1
ANTAGONISM ON SENSORI-MOTOR
PERFORMANCE AND BOLD RESPONSE
P. van Ruitenbeek, A. Vermeeren, M.A. Mehta, E. Drexler,
W.J. Riedel
Histamine plays a role in cognitive functioning and sen-
sori-motor functioning in particular, comprising of many
processes from visual input to motoric output. However,
the histaminergic role in these processes is largely
unknown. Recently, effects of H1-antagonism on brain
evoked potentials indicated that sensory visual processes
are affected, but not response related processes. In addition,
the brain may attempt to compensate for this impairment
by speeding up response choice related processes. To
establish the effects on visually related processes and test
the ‘compensation’ hypothesis, we conducted a functional
Magnetic Resonance Imaging (fMRI) study to assess brain
activity changes related to increased visual and response
choice task demands and interaction with H1-antagonism.
Using a 3-way cross over design, 9 subjects (5 female)
with a mean age of 20.6 years (SEM ±0.8) received single
oral doses of dexchlorpheniramine 4 mg (D4), lorazepam
1 mg and placebo. Brain activity was measured in a 3T
MRI scanner 2 h post dose when subjects performed a
choice reaction time task. Subjects were required to
respond with their left or right hand as indicated by the
stimulus presented left or right side of the screen and using
their index or middle finger as indicated by the identity
of the stimulus. Task manipulations were visually intact
or degraded stimuli and compatible or incompatible
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responses, manipulating visual and response choice pro-
cessing demands.
Degraded stimuli increased brain activity in primary
visual areas, but incompatible responses did not activate a
response choice network. D4 reduced brain activity fol-
lowing a degraded stimulus in nine areas, but had no
expected effect in the visual cortex. D4 also did not interact
with response choice demands. There was no evidence of
compensatory activity in response choice related areas
following degraded stimuli and D4, but compensation
might have taken place in language, working memory and
attention related areas.
Centre for Neuroimaging Sciences, Institute of Psy-
chiatry, King’s College London, De Crespigny Park,











Viral infections have been associated with the initiation,
protection and exacerbation of asthma; interactions with
other stimuli such as allergens have also been demon-
strated. Among the different respiratory viruses, human
rhinoviruses (RV) have been associated with the majority
of asthma exacerbations and induction of asthma in
childhood. RV are able to infect and replicate in the lower
respiratory epithelium, where they induce a local inflam-
matory response. Nevertheless, the immune response to RV
is impaired in atopic individuals with reduced IFN-gamma
responses and defective co-stimulation. Defects in the
interferon response are characteristic in atopic asthmatics
leading to diminished viral clearance and possible perpet-
uation of inflammation. Epithelial cells, if placed in an
atopic environment, fail to clear the virus and are suscep-
tible to increased cytotoxicity. Simultaneous or subsequent
exposure to allergen further increases inflammatory
responses through an NF-kB mediated mechanism. RV
infections are also able to induce production of remodel-
ing-associated factors, such as VEGF and FGF-2, which
further augmented in an atopic environment may result in
virus-induced remodelling. In the clinical setting, atopic
children with virus-induced asthma are much more likely
to continue being hyperresponsive than non-atopic
children.
Allergy Dpt, 2nd Pediatric Clinic, University of Athens,
Athens, Greece. E-mail: ngp@allergy.gr
H1/H2 RECEPTORS IN ALLERGIC
AND IMMUNE RESPONSES
M. Jutel
Histamine (H) has been shown to affect chronic inflam-
mation and to regulate essential events in the immune
response. These effects are due to the differential expres-
sion and regulation of 4 distinct receptors (H1–H4R). The
discovery of reciprocal regulation of T cell activity by H1
and H2R activation, indicating H-cytokine cross-talk, plus
characterization of the H4R and its expression on many
immune and inflammatory cells, has led to a re-evaluation
of H actions. H is involved in the regulation of immune
responses and haematopoiesis and affects many cells
including macrophages, dendritic cells (DC), T and B
lymphocytes and endothelial cells. H directly affects DC
(both immature and mature) which express all 4 R. In the
differentiation process of DC1 from monocytes, H1R and
H3R act as positive stimulants which increase antigen-
presentating capacity, proinflammatory cytokine produc-
tion and Th1 priming activity. However, activation of H2R
acts as a suppressant for antigen-presentation by enhancing
IL-10 production and inducing IL-10-producing T cells or
Th2 cells. Differentiation of monocytes into macrophages
also induces a dramatic down-regulation of H2R, while
differentiation into DC has no significant influence on H2R
expression. Over-expressed H1R is functionally active and
induces increased production of IL-8 in H-stimulated
macrophages. H intervenes in the Th1, Th2, Treg cell
balance and thus antibody formation. Differential patterns
of HR expression on Th1 and Th2 cells determine reci-
procal T cell responses after H stimulation. Th1 cells show
a predominant, but not exclusive, expression of H1R while
Th2 cells show increased expression of H2R. H enhances
Th1-type responses via the H1R, while both Th1- and Th2-
type effects are negatively regulated by H2R. Deletion of
H1R in mice causes suppression of IFN-a and dominant
secretion of Th2 cytokines (IL-4 and IL-13) while H2R
deletion leads to upregulation of both Th1 and Th2
cytokines. Bphs, a non-major histocompatibility complex-
related gene involved in susceptibility to many autoim-
mune diseases, has been linked to the H1R in mice and
knockout mice show delayed disease onset and decreased
severity in models of experimental allergic encephalomy-
elitis. H stimulation also induces IL-10 secretion via H2R.
Increased IL-10 production in both DC and T cells may
provide an important regulatory mechanism for the control
of inflammatory functions. Various cytokines regulate the
production of H and its R expression. IL-3 and GM-CSF
enhance H release from basophils and SCF acts similarly
on mast cells. IL-3 stimulation significantly increases H3R
expression on Th1 but not Th2 cells. H also interferes with
induced peripheral tolerance. H induces IL1-10 production
from DC and enhances the suppressive activity of TGF-a
on T cells. All of these effects are via the H2R which is
highly expressed on Th2 cells and mediated through sup-
pressed IL-4 and IL-13 production and T cell proliferation.
This suggests that the H2R may be essentially involved in
peripheral tolerance or active suppression of inflammatory/
immune responses. Future work on the role of H and other
G-protein-coupled R in inflammation and the immune
system is required.
Dept. Clinical Immunology, Wroclaw Medical Univer-
sity, Poland. E-mail: mjutel@ak.am.wroc.pl
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HISTAMINE H1 AND H4 RECEPTOR
ANTAGONISTS DO NOT PREVENT ACUTE
SKIN LESIONS IN A CANINE MODEL
OF ATOPIC DERMATITIS
W. Bäumer, J. Stahl, K. Sander, H. Stark,
M. Kietzmann, T. Olivry
Highly selective histamine H4 receptor (H4R) antagonists
display anti-inflammatory and anti-pruritic in vivo efficacy
in mice. Our objectives were to test H4R antagonists for
skin lesion prevention in a canine model of atopic derma-
titis and to compare their efficacy to that of two H1R
antagonists that are used as add-on therapy to treat acute
atopic lesions and pruritus in dogs.
In these blinded, placebo and active-controlled cross-
over experiments, six Maltese-beagle atopic dogs
sensitized to house dust mite antigen were treated topically
with 1% solutions of the H4R antagonists JNJ7777120 or
JNJ28307474 (kindly provided by Johnson & Johnson,
Pharmaceutical Research & Development, La Jolla, USA)
or orally with JNJ28307474 at 15 mg/kg before and
immediately after allergen challenge. Pretreatment with
0.015% triamcinolone acetonide solution served as a
positive control. In a second trial, the H1R antagonists,
hydroxyzine pamoate (2 mg/kg twice daily) and cetirizine
(0.5 mg/kg once daily) were administered orally before
challenge. Twenty-four hours after challenge by epicuta-
neous application of house dust mite antigen,
erythematous skin lesions were scored. Lesional scores
after challenge were not significantly different after pla-
cebo, JNJ28307474 (orally or topically administered) and
JNJ7777120 (topically administered). Hydroxyzine and
cetirizine also did not reduce the median score of the
placebo treatment, while triamcinolone acetonide pre-
vented all dogs from developing any lesions. Increased
concentrations of histamine, as determined by microdi-
alysis, were detected in lesions only during the initiation
stage of the process.
Thus, the administration of H1R or H4R antagonists did
not prevent the development of acute atopic skin lesions in
this canine atopic dermatitis model. However, the gluco-
corticoid positive control led to the expected prevention of
lesions.
Dept. Pharmacology, Toxicology and Pharmacy, Uni-
versity of Veterinary Medicine Hannover, 30559 Hannover,
Germany. E-mail: wolfgang.baeumer@tiho-hannover.de
CHANGES IN PLASMA HISTAMINE
CONCENTRATION IN A DAIRY HERD AFTER
CHANGING THE FLOORING FROM SLATTED
CONCRETE TO SLATTED RUBBER MATS
F. Ahrens, S. Platz, C. Link, H.H.D. Meyer, M.H. Erhard
Lameness in dairy cows is a major economic and welfare
issue. Histamine seems to play a crucial role in laminitis, a
condition that impairs blood circulation in horn-producing
tissue of the foot. Therefore, the aim of this study was to
investigate the effect of changing the flooring in the alleys
of a barn from slatted concrete to slatted rubber mats on
hoof health, plasma histamine concentration, stress and the
immune system in 44 loose-housed Brown Swiss dairy
cows.
Cows were examined for hoof disorders of the hind
limbs (haemorrhages, white line fissures, ulcers, heel horn
erosion, and digital dermatitis). Evaluations were carried
out when the cows were housed on a concrete slatted floor
and after 4 and 10 months on soft flooring (slatted rubber
mats, 29 mm thick). In 15 cows, 3 blood samples were
drawn when the cows were still housed on concrete slats
and another 6 samples were taken when the cows were
housed on rubber slats. Histamine concentration and
parameters for assessing the stress response (cortisol) and
the immune system (immunoglobulin G) were measured in
plasma by HPLC (histamine, cortisol) or by ELISA
(immunoglobulin G).
Changing the floor from slatted concrete to slatted
rubber mats significantly increased the score for white line
fissures (after 10 months on rubber mats) while the other
hoof disorders were not affected. Immunoglobulin G and
cortisol concentration in the plasma increased when the
cows were housed on rubber slats. The opposite applied to
the plasma histamine concentration which was significantly
higher when the cows were housed on concrete.
Thus covering slatted concrete flooring with slatted
rubber mats affected hoof health only partially but signif-
icantly influenced blood parameters of inflammation
(histamine), stress (cortisol), and the immune system
(immunoglobulin G) in dairy cows.
Department of Veterinary Science, Chair of Animal
Welfare, Ethology, Animal Hygiene, and Animal Housing,
Faculty of Veterinary Medicine, Ludwig-Maximilians-




IMAGING HISTAMINE H1 RECEPTORS USING
PET AND [11C]DOXEPIN: FURTHER PROGRESS
K. Yanai, T. Nakamura, M. Tashiro, T. Watanabe
Histaminergic neurons are exclusively located in the pos-
terior hypothalamus and project their fibers to almost all
regions of the brain. We have now examined the functions
of these neurons in humans using positron emission
tomography (PET). We here summarize our recent work on
[11C]doxepin-PET studies, including gender differences in
histamine H1 receptors and the ‘hangover effects’ of noc-
turnally-administered sedating antihistamines.
We found that there are gender differences in the inter-
stitial nuclei of the anterior hypothalamus. The nuclei of
homosexual men are only one-half the size of those of het-
erosexual men. Previous studies demonstrated the sexual
dimorphism of brain histamine and behaviour in animals. In
accordance with animal studies, normal female subjects
show significantly higher binding of [11C]doxepin to H1
receptors in the cerebral cortical areas than male healthy
volunteers (N = 12). Gender differences should then be
taken into consideration in studies of neuronal histamine.
Antihistamines are frequently used for the treatment of
allergic diseases, common cold, cough, fever or motion
sickness. Sedation is a well-recognized central side-effect
of first-generation antihistamines and is caused by block-
ade of the histaminergic neuron system in the human brain.
To avoid daytime sedation, antihistamines are often
administered at night. However, the next-day residual
sedative effect of antihistamines, the so-called ‘hangover
effect’, has never been quantitatively evaluated by PET.
Diphenhydramine (50 mg), a sedating antihistamine,
retained predominant residual effects as demonstrated by
its high central H1 receptor occupancy (average 44.6%)
even 12 h after taken orally (N = 8). Attention should thus
be paid to a possible cognitive decline or impaired per-
formance on the day after treatment with sedating
antihistamines even when they are administrated at night.
Dept. of Pharmacology, Tohoku University Graduate
School of Medicine, Sendai, 980-8575, Japan. E-mail:
yanai@med.tohoku.ac.jp
THE EFFICACY AND SAFETY OF TREATMENT
OF ALLERGIC CHILDREN WITH NEW
GENERATION OF ANTIHISTAMINES
E. Savtchenko, M. Ferrer, M. Morais-Almeida, M. Guizova,
M. Markelova, D. Kulchenko, R. Khanferyan
The new generation of histamine H1 receptor antagonists
have been shown to be very efficacious and safe. They are
mainly recommended for the treatment of allergic rhinitis,
urticaria and other allergic conditions. The aim of this
study was to investigate parent and physician satisfaction
with oral antihistamine treatment in children and to com-
pare levocetirizine with other antihistamines. In an
international Observational Survey in Children with
Allergic Rhinitis (OSCAR), children (2–12 years old with
a history of allergic conditions) were enrolled from 424
primary-care/specialist allergy clinics from Bulgaria, India,
Portugal, Romania, Russia, South Korea and Spain. At
the consultation, parents and physicians completed ques-
tionnaires evaluating their satisfaction with specific
antihistamines currently used for management of the
child’s allergic condition, plus their intention for future use
of that treatment. A total of 4581 patients were enrolled:
3048 (66.5%) had allergic rhinitis (55.9% persistent aller-
gic rhinitis and 44.1% intermittent allergic rhinitis) and 663
(14.5%) had urticaria as primary conditions. Also, 2465
patients (53.8%) suffered from other allergic conditions,
including allergic asthma, atopic dermatitis, food allergy
and drug hypersensitivity. Levocetirizine and fexofenadine
scored highest for efficacy, tolerability and global satis-
faction, and for impact on the child’s ability to function at
school, quality of school activities and quality of sleep.
Parent and physician satisfaction scores were in close
agreement and demonstrated a significantly greater global
satisfaction for the second-generation antihistamines. This
study shows that second-generation antihistamines, par-
ticularly levocetirizine and fexofenadine, have superior
risk:benefit ratios compared to first-generation drugs.
Levocetirizine is thus one of the drugs of choice in the
treatment of allergic diseases in children.
Kuban State Medical University, Krasnodar, 350063,
Russia. E-mail: ragweedasta@yahoo.com
INVOLVEMENT OF HISTAMINE RECEPTORS
IN TOTAL AND ALLERGEN-SPECIFIC
IgE SYNTHESIS
N.O. Milchenko
Effects of histamine are mediated through different types
of receptors, which are all G protein-coupled. It has been
shown that histamine (H) is involved in IgE regulation.
This study assesses the impact of H1, H2 and dual H3/H4 H
receptor antagonists on IgE synthesis by peripheral blood
mononuclear cells (PBMC) from healthy donors plus
patients sensitized to ragweed pollen. Supernatants of
9-day cultures of peripheral mononuclear blood cells
(PBMC) from healthy donors and ragweed sensitive
patients were assayed for total and specific anti-ragweed
IgE by the CAP FEIA method (Phadia) and ELISA.
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H1 (Loratadine) and H2 (Cimetidine) antagonists as well as
the H3/H4 antagonist, Imoproxifan (IMP) (Ki = 0.26 nM)
were used as H receptor antagonists. PBMC from ragweed
sensitive patients were also stimulated by ragweed allergen
(Greer) with the 10 IU concentration of antigen E. Level of
the synthesis of homocytotropic anti-ragweed specific IgE-
Ab has been studied by passive cutaneous anaphylaxis in a
mouse model. It was shown that H1 and H2 antagonists
injected before immunization bidirectionally influenced
IgE-specific Ab synthesis in mice. Simultaneous blockade
of H1 and H2 receptors prior to injections of H3/H4
antagonist IMP modulates the impact of this antagonist on
IgE-Ab synthesis. In vitro studies showed that simulta-
neous blockade of H1 and H2 receptors dose-dependently
increased IgE synthesis by PBMC of healthy donors
incubated with H3 receptor agonist R-a-methyl-histamine
(RMH). Similar results in total IgE synthesis was achieved
in culture of PBMC of ragweed sensitive patients. IgE
specific Ab synthesis modulated similarly total IgE syn-
thesis when PBMC culture of ragweed sensitive patients
were cultivated in presence of H1, H2 and H3/H4 histamine
antagonists.
Thus, different types of H receptor antagonists modulate
total IgE plus allergen specific IgE synthesis in healthy
donors and ragweed-sensitive patients. Simultaneous
blockade of H1 and H2 receptors influence the IgE-modu-
latory effects of an H3/H4 antagonist and H3 agonist.
Kuban State Medical University, Krasnodar, 350063,
Russia. E-mail: nadya270100@mail.ru
DYNAMICS OF SERUM CONCENTRATION
OF THE HISTAMINE, TNF-a AND IL-10 IN
PATIENTS WITH RHEUMATOID ARTHRITIS
TREATED WITH INFLIXIMAB
S.P. Oransky, L.N. Eliseeva, J.V. Vasinova,
R.A. Khanferyan
Here is no unique understanding of the effects of histamine
and its possible influence on cytokine profile in autoim-
mune diseases, particularly in rheumatoid arthritis (RA).
For a long time opinion existed that the prevalence of
proinflammatory effects of histamine in RA was mediated
through H1 receptors. Later from experimental evidence,
the ability of histamine, via the H2 receptor, could switch
Th1 lymphocytes to Th2 types with the increase in syn-
thesis of anti-inflammatory cytokines.
The purpose of this study was to investigate the
dynamics of serum histamine, TNF-a and IL-10 in patients
with RA, treated with monoclonal antibodies against TNF-
a (infliximab). 25 patients with active RA and a control
group of 12 healthy volunteers were included in the clinical
trial. Serum histamine and levels of TNF-a and IL-10 were
measured before and after five intravenous infusions of
infliximab.
It was shown that serum concentration of histamine in
healthy donors and RA patients before treatment did not
differ significantly with a level of 0.8 (0.2; 1.1) ng/ml in
RA. The concentration of cytokines was significantly
higher when compared with the control group: in RA
patients the concentration of TNF-a was 178.1 (101; 243)
and IL-10 302.5 (208.3; 510) pg/ml. After infliximab
therapy there was a significant decrease in the concentra-
tion of TNF-a of up to 74.3 (59; 120) pg/ml (p = 0.02).
Infliximab did not influence the serum concentration of
IL-10. Histamine concentration after infliximab injection
was slightly increased to 1.4 (1.2; 1.9) ng/ml (p = 0.04).
Therefore it was shown that infliximab has the ability to
reduce proinflammatory cytokine activation in RA patients
and this effect was accompanied by an increase in hista-
mine concentration.
Kuban State Medical University, str. Sedin, 4, Krasno-
dar 350063, Russia. E-mail: s_oransky@inbox.ru
EFFICACY OF IMMUNOMODULATORY
THERAPY IN CHILDREN WITH ATOPIC
DERMATITIS
E.A. Kokov, L.A. Kokova, N.V. Kolesnikova,
G.A. Chudilova, L.V. Lomtatidze
It has been shown previously that the inclusion of the new
Russian immunomodulatory drug Licopid (active ingredi-
ent is N-Acetylglucosaminyl-(b1 ? 4)-N-acetylmuramyl-
alanyl-D-isoglutamine) into the complex therapy of
IgE-mediated atopic dermatitis (AD) increases the efficacy
of the treatment. The purpose of this study was to examine
the clinical effects of the therapy of 85 children (6–9 years)
with IgE-mediated moderate AD accompanied with local
infections. Patients without infections at the moment of
observation were divided into 3 groups: group A (25
children) received only standard therapy (UT), group B (30
children) received UT in combination with Licopid at a
total dose of 25 mg, and group C (30 children) received a
combination of UT with Licopid at a higher dose of 50 mg.
Clinical efficacy according to SCORAD parameters was
analyzed before the treatment and 1, 2 and 6 months after
the treatment. Analysis of results showed a decrease in the
number of aggravations of AD in clinical group C, in
comparison to a prevalence of aggravations in groups A
(3.4-fold) and B (twofold). Moreover, there was a marked
decrease in the number of aggravations of accompanying
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diseases in group C. In total, these results suggest that the
modified scheme of therapy with high doses of Licopid
(50 mg in total) may be highly efficacious in the treatment
of children with IgE-mediated moderate AD.
Kuban State Medical University, Krasnodar, 350063,
Russia. E-mail: troickaya@rambler.ru
DEVELOPMENT OF A TOPICAL
PREPARATION OF DIMEBON
K.N. Koryanova, A.V. Majorova, E.F. Stepanova,
I.A. Savenko
Topical treatment of allergic dermatitis is one of the
principle problems in modern dermatology. Dimebon, an
antihistamine drug, offers anti-allergic local medicinal
potential. Dimebon induces anti-allergic effects via
multiple mechanisms: blocking of H1-histamine receptors
and partially blocking muscarinic acetylcholine and
serotonin receptors. Until now, Dimebon has not been
utilized topically. Aim of this investigation was
(a) preparation of Dimebon cream, (b) choice of additive
substances, (c) technological optimisation of the derma-
tological cream. We used biopharmaceutical in vitro and
pharmacological tests. The detailed biopharmaceutical
research used dialysis though a membrane. Polyethylene
glycol 400, 4000, carbopol 940, collagen, methyl cellu-
lose and the complex of chitosan-flocare were used as
base-carriers. Flocare was used as an emulsifying, solu-
bilizing additive substance. The degree of release of the
active component (Dimebon) was determined by mea-
suring optimal density of the solution after regular
periods of dialysis. Investigations of this kind were
carried out using the choice of the optimal penetrator,
and the following additive compounds were used: pro-
pylene glycol, glycyrram, polyethylene glycol 400.
Investigations to select the appropriate conserving agent
were carried out using standard culture of microorgan-
isms, such as: Escherichia coli, Pseudomonas
aeruginosa, Staphylococcus aureus, Candida albicans.
The investigation resulted with the complex of chitosan-
flocare being selected as an optimal base, polyethylene
glycol 400 as a penetrator, and benzalconium chloride as
the conserving agent. The pharmacological methods of
investigation had distinct positive results. Thus, the first
preparation of an anti-allergic cream with Dimebon has
been made. This cream can be used in allergic skin
conditions.
Pyatigorsk State Pharmaceutical academy, Pyatigorsk
RUDN, Moscow. E-mail: kskor-16@mail.ru
POSSIBILITIES OF USING DIMEBON-GEL
WITH ANTIHISTAMINIC ACTIVITY
IN DERMATOLOGY
A.V. Majorova, K.N. Koryanova, E.F. Stepanova,
I.A. Savenko
Currently cosmetic production is an important consider-
ation of the pharmaceutical market. In Russia there is an
increase in the prevalence of dermatological cellular tissue
disease. The tendency of this increase is stimulating the
investigations into new medicinal products for dermato-
logical conditions. The aim of this investigation was to
examine the use of a dermatological medicine, namely the
antihistamine compound Dimebon. Dimebon is a first
generation histamine H1 antagonist which was synthesized
in Russia. It is a derivate of carboline, which is used as a
therapy for various dermatological conditions such as
oedema, itching, eczema and some reactions resulting from
insect-bites. Here we used chitosan-aminosaccharide which
is able to heal the injured skin. In cosmetics, highly-
astringent hydro-gels of chitosan are used because they
exhibit high penetration into the skin, as well as having
immune-modulating, anti-microbial and antifungal proper-
ties. Another frequently used compound in dermatological
medicines, perfume-production and cosmetics as a hydro-
filling base is polyethylene glycol 400 and it is relatively
non-toxic. Benzalconium chloride has antiseptic and pre-
serving properties. We have used in vitro biopharmaceutical
methods for our investigations. Additionally we have car-
ried out pharmacological tests to study the anti-allergic
action of the Dimebon-gel. As a result of our comparative
investigations, we have found that the best ones use chito-
san. The Dimebon-gel can be used as an antiallergic
treatment in complex therapy and treatment of dermato-
logical conditions resulting from the use of some cosmetic
products. Therefore the use of the Dimebon-gel appears to
be very promising in dermatological therapy.
Pyatigorsk State Pharmaceutical Academy, Pyatigorsk,










NEW TOOLS FOR STUDYING OLD
QUESTIONS: ANTIBODIES FOR HISTAMINE
METABOLIZING ENZYMES
H.G. Schwelberger, J. Feurle, G. Houen
Many findings on histamine metabolism obtained in animal
models have yet to be confirmed in humans, which is
mostly due to lack of suitable tools for studying histamine
formation and inactivation in man. Therefore, we aimed to
produce highly sensitive and specific monoclonal anti-
bodies for human histamine metabolizing enzymes that
facilitate the detection and quantitation of the respective
proteins at the cellular and subcellular level.
Complete and partial cDNAs encoding human diamine oxi-
dase (DAO) and histamine N-methyltransferase (HMT) were
expressed as GST fusions in E. coli, purified to homogeneity and
used for immunization of mice to obtain monoclonal antibodies.
These antibodies were screened for specificity and sensitivity
and then used to analyze the expression and localization of DAO
and HMT in human tissue sections and homogenates by
immunohistochemistry and immunoblotting.
Five different monoclonal antibodies specific for human
DAO were obtained that can detect DAO with 100-fold
greater sensitivity than the most sensitive enzymatic assays
currently available. Using these antibodies allowed us to
confirm the expression and cellular localization of DAO in
various human tissues such as kidney, intestine and placenta
where the presence of the enzyme had previously been
deduced from activity measurement and DAO mRNA
analysis. Due to the high sensitivity, DAO was also detected
in biological fluids that previously evaded unequivocal proof
of DAO enzymatic activity such as urine. Monoclonal anti-
bodies specific for human HMT are currently being tested
and results on the expression of HMT in human tissues
should be available shortly.
New monoclonal antibodies not only allow a compre-
hensive quantitative evaluation of the expression of
histamine metabolizing enzymes at the cellular level in
man but will also facilitate sensitive analyses of disease
associated alterations of these proteins.
Molecular Biology Laboratory, Department of Visceral,
Transplant and Thoracic Surgery, Medical University
Innsbruck, 6020 Innsbruck, Austria. E-mail: hubert.sch-
welberger@i-med.ac.at
CHARACTERIZATION OF DIAMINE OXIDASE
FROM HUMAN SEMINAL PLASMA
H.G. Schwelberger, J. Feurle
The preparation and characterization of native human
diamine oxidase (DAO) is difficult because the enzyme is
expressed at relatively low levels in man, and healthy
human tissues containing DAO are difficult to obtain in
sufficient quantity. Reports in the older literature indicating
a considerable DAO activity in human seminal plasma
prompted us to purify and characterize the enzyme from
this readily available source.
Human seminal plasma, the cell-free fraction of the
semen, was fractionated by consecutive affinity binding on
Heparin Sepharose, hydrophobic interaction on Phenyl
Sepharose, anion exchange on CIM-QA, and size frac-
tionation on Superdex 200 to obtain a nearly homogenous
DAO protein. DAO was characterized enzymatically and
by various gel electrophoretic techniques.
DAO was purified from human seminal plasma ca.
300-fold with ca. 20% yield. The purified protein appears
homogenous on two-dimensional IEF/PAG and monomeric
seminal plasma DAO migrates at ca. 100 kDa similar to
kidney DAO but is slightly smaller than placenta DAO,
which is due to different glycosylation of the protein in
different tissues. The enzymatic properties of seminal
plasma DAO are very similar to DAO proteins from other
human tissues with histamine and aliphatic diamines being
the preferred substrates and significant conversion of
polyamines at higher substrate concentrations.
Human seminal plasma DAO can rapidly be purified and
is enzymatically and electrophoretically similar to DAO
proteins from other human tissues. Likely sources of seminal
plasma DAO are the prostate and testis where DAO
expression is detectable at the mRNA level. The functional
importance of DAO in the semen remains to be determined.
Molecular Biology Laboratory, Department of Visceral,
Transplant and Thoracic Surgery, Medical University





TO IMPROVE H4R SELECTIVITY
R. Geyer, P. Igel, A. Buschauer
The human histamine H4 receptor (hH4R) is considered a
potential drug target, for instance, for treatment of
inflammatory and allergic diseases. Potent and selective
ligands including agonists are required as pharmacological
tools. Many agonists show only low or insufficient H4R
selectivity. Also the investigation in animal models is
hampered by species-dependent discrepancies regarding
potencies and histamine receptor subtype selectivities.
Very recently, we identified imidazolylalk-
ylcyanoguanidines as highly potent and selective hH4R
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agonists. Highest potency resided in compounds with a
tetramethylene linker, connecting the imidazole and the
cyanoguanidine moiety as in UR-PI376. Introducing a
conformationally restricted cyclopentylene linker further
increased H4R agonistic potency and selectivity as in trans-
(+)-UR-RG98. Nevertheless, these compounds have still
some affinity for histamine receptors other than the H4R.
Therefore, by analogy with a strategy which was very
successful in the H2R agonist field, we applied a bioisos-
teric approach, aiming at H4R agonists with further
improved selectivity, and synthesized a series of hetar-
ylbutylcyanoguanidines containing, for instance,
aminotriazoles or aminopyrimidines as potential bioisos-
teres of the imidazole ring.
Potencies, intrinsic activities and selectivities of these
compounds were determined in GTPcS assays using
membrane preparations of Sf9 insect cells, expressing the
respective hHR subtype (H3/4R). Unfortunately, only a few
of the investigated compounds showed relevant H4R
activity. Even minor variations like the introduction of a
methyl group in 2- or 5-position of the imidazole ring,
resulted in a dramatic decrease in H4R agonistic activity.
Although the bioisosteric replacement of imidazole did not
yield potent H4R ligands so far, the synthesized compound
library will be useful in molecular modelling studies to
refine the H4R receptor model and to design new H4R
agonists.
Institute of Pharmacy, Dept. of Pharmaceutical/Medic-
inal Chemistry II, University of Regensburg, 93040
Regensburg, Germany. E-mail: Roland.Geyer@chemie.
uni-regensburg.de
SECOND AND THIRD EXTRACELLULAR
LOOPS OF THE HISTAMINE H4 RECEPTOR
ARE INVOLVED IN RECEPTOR ACTIVATION
I. Brunskole, A. Strasser, R. Seifert, A. Buschauer
A recent study from our laboratory revealed substantial
differences in pharmacological profile of human (h) and
canine (c) histamine H4 receptor (H4R). Surprisingly,
thioperamide and 1-[(5-chloro-1H-indol-2-yl)carbonyl]-4-
methylpiperazine (JNJ7777120), acting as inverse agonists
at hH4R via Gi/o coupling, exhibited partial agonistic
activity at cH4R.
In order to elucidate the contribution of extracellular
regions to species differences between hH4R and cH4R, we
generated chimeric receptors by replacing corresponding
domains of hH4R with canine N-terminus (hcNTH4R) and
three canine extracellular loops, respectively (hcE1H4R,
hcE2H4R and hcE3H4R). Receptors were expressed in Sf9
insect cells and subsequently characterised in [3H]
histamine binding experiments and in steady-state GTPase
activity assays, where histamine, 5-methylhistamine, thio-
peramide, JNJ7777120 and clozapine were examined.
The exchange of N-terminus or first extracellular loop
did not affect hH4R pharmacology. The influence of altered
second or third extracellular loop of hH4R on potency of
examined ligands was ligand-specific rather than agonist-/
inverse agonist-specific. Moreover, almost full inverse
agonistic activity of thioperamide at hH4R was strongly
reduced at hcE2H4R and hcE3H4R. Most strikingly,
JNJ7777120, a weak inverse agonist at hH4R, exhibited
partial agonistic activity at hcE2H4R and hcE3H4R. Molec-
ular dynamic simulations suggest that the second and the
third extracellular loop are, independently of each other,
involved in partial/inverse agonism of JNJ7777120. Further-
more, the second as well as third extracellular loops do not
directly interact with JNJ7777120 in the binding pocket.
In conclusion, the second and third extracellular loops of the
H4R are involved in the receptor activation process.
Department of Pharmaceutical and Medicinal Chemis-
try II, Institute of Pharmacy, University of Regensburg,






T. Birnkammer, A. Kraus, G. Bernhardt, S. Dove, S. Elz,
R. Seifert, A. Buschauer
NG-Acylated hetarylpropylguanidines represent a new
class of potent histamine H2 receptor (H2R) agonists. Very
recently, a tremendous increase in potency was achieved by
applying the bivalent ligand approach to acylguanidine-
type H2R agonists. The combination of two hetarylpro-
pylguanidines by alkanedioyl spacers with 6–8 methylene
groups led to the most potent H2R agonists known so far:
These compounds proved to be up to two orders of mag-
nitude superior to the monovalent acylguanidines and up to
4,000-fold more potent than histamine.
The present study was focused on the chemical nature of
the spacer as well as on ‘‘unsymmetrical bivalent ligands’’
bearing two different sets of pharmacophore groups.
Therefore, various bivalent acylguanidines were synthe-
sized by connecting the guanidine groups of two molecules
with different diacyl spacer. The synthesized compounds
were pharmacologically investigated for H2R agonism at
isolated guinea pig (gp) right atria and in steady-state
GTPase assays using human (h) and gpH2R-GsaS fusion
proteins. Moreover, the histamine receptor selectivity
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profile (H2R vs. H1R, H3R, H4R) was determined (GTPase
assays).
This study demonstrates the structural requirements of
bivalent acylguanidine-type H2R agonists and substantiates
previous results obtained with symmetrical compounds,
suggesting that the gain in potency is due to the interaction
with an additional binding site at the same receptor mol-
ecule rather than by bridging the binding pockets of a
hypothetical receptor dimer. The synthesized compounds
are promising pharmacological tools for further investiga-
tions of hypothetical H2R dimers. In this respect, successful
approaches and results from the H2R field may be exem-
plary for and applicable to other GPCRs.
Institute of Pharmacy, University of Regensburg, Univer-
sitätsstraße 31, D-93053 Regensburg, Germany. E-mail:
tobias.birnkammer@chemie.uni-regensburg.de
(UN-)SUBSTITUTED ARYLTRIAZINE
DERIVATIVES AS HISTAMINE H4 RECEPTOR
LIGANDS
T. Karcz, J. Handzlik, J. Ner, T. Kottke, S. Schwed,
R. Seifert, H. Stark, K. Kieć-Kononowicz
The histamine H4 receptor (H4R) appears to be a prominent
target for drug development. It is mainly expressed in bone
marrow as well as in peripheral leukocytes and is claimed
to play an important role in a wide variety of immuno-
logical and inflammatory processes. Therefore, the
potential H4R ligands could provide innovative therapies
for different immuno-based diseases.
In our recent studies, we considered the 2-amino-4-(4-
methylpiperazin-1-yl)-1,3,5-triazine structure as a scaffold
for development of novel histamine H4 receptor ligands,
based on promising pharmacological results for structurally
related compounds.
The present work is the continuation of structure–
activity relationships investigation in the group of triazine
derivatives. Fourteen derivatives with a diversity of sub-
stituents placed in different positions of aryl ring were
obtained. Within the discussed study, affinity data were
collected in radioligand binding assays, using the model of
Sf9 insect cells, transiently expressing recombinant human
histamine H4 receptors. In addition the drug-likeness of
tested compounds has been estimated by means of com-
putational analysis.
The evaluated series of compounds showed in vitro
affinities in the micromolar and submicromolar concen-
tration range. The affinity of the compounds showed great
susceptibility to the kind and pattern of aryl ring substitu-
tion. The Ki value obtained for the most potent compound
was 203 ± 65 nM.
This work was partly supported by the Polish Ministry
of Science and Higher Education Grants No: 594/N-COST/
2009/0, K/ZDS/000727 and the COST Action BM0806.
Department of Technology and Biotechnology of Drugs,
Jagiellonian University, Medical College, Kraków, 30-688,
Poland. E-mail: tadeusz.karcz@gmail.com
CHLOROPHENOXYL DERIVATIVES
AS HISTAMINE H3R ANTAGONISTS
D. Ła _zewska, T. Kottke, L. Weizel, S. Schwed, T. Karcz,
H. Stark, K. Kieć-Kononowicz
The H3R is involved in the central and peripheral regula-
tion of levels of histamine and other neurotransmitters (e.g.
acetylcholine, noradrenaline, dopamine, serotonin, GABA,
glutamate and substance P). Intensive pharmacological
studies suggest the utility of H3R antagonists/inverse
agonists in CNS diseases (e.g. narcolepsy, ADHD, Alz-
heimer’s disease, schizophrenia, epilepsy), allergic rhinitis,
obesity and pain. Many pharmaceutical companies and
academic researchers have synthesized a large number of
highly potent H3R antagonists/inverse agonists. Some of
the compounds are undergoing evaluation in clinical
development. Especially interesting is pitolisant (1-{3-[-
3{-4-chlorophenyl) propoxy]propyl}piperidine), which is
progressing through phase III clinical trials.
The present work is a continuation of our previous
works in the histamine H3R field. As the lead structure for
these studies, we have chosen pitolisant and 3- or 4-chlo-
rophenoxy analogues of this compound have been
prepared. Compounds with four secondary amines as a
basic group (piperidine, 3- or 4-methylpiperidine and
azepine) have been synthesized. A length of the alkyl
spacer between an amine moiety and a chlorophenoxy ring
has been also changed. The desired compounds were
obtained by the direct reaction of prepared chloro-
phenoxyalkyl bromides with corresponding amines.
Histamine H3R affinities of the synthesized compounds
were evaluated at the human receptor. Displacement of
[3H] Na-methylhistamine from HEK-293 cells stably
expressing hH3R was measured. Most compounds showed
moderate histamine H3R affinities (hH3R 100 nM \
hKi \ 500 nM).
Generally, the most potent were 3-methylpiperidine
derivatives and the length of the alkyl chain influenced the
H3R potency.
This work was partly supported by grant No. 594/N-
COST/2009/0 and COST Action BM0806.
Dept. Technology and Biotechnology of Drugs, Jagiel-












CONTRIBUTION OF THE VASCULAR
ENDOTHELIUM IN THE HISTAMINE H3
AND H4 RECEPTOR-MEDIATED EFFECTS IN
BLOOD VESSELS IN ADJUVANT ARTHRITIS
K. Kyriakidis, E. Tiligada
This study sought to investigate the involvement of the
vascular endothelium in the effects mediated by H3 or H4
receptors (HxR) in large arteries and veins in rats with
adjuvant arthritis. Male Wistar rats of *300 g b.w. received
complete Freund’s adjuvant (CFA) i.d. and/or 1 and 3 mg/kg
or 10 and 30 mg/kg i.p. of the H3R and H4R inverse agonists/
antagonists GSK334429 (AD Medhurst, GSK, Essex, UK)
and JNJ7777120 (RL Thurmond, JNJ, CA, USA), respec-
tively. Following sacrifice at day 20, abdominal aorta (AA)
and inferior vena cava (IVC) were dissected out. Endothe-
lium was removed by 30 s perfusion with sodium
deoxycholate, using a short Abbocath 22 intravenous cath-
eter. Tissue histamine either in the presence or following
removal of the endothelium was quantified fluorophoto-
metrically. CFA administration resulted in the development
of arthritic signs in animal paws. Statistically significant
reductions in histamine levels in both AA and IVC were
observed following JNJ7777120 administration, while
GSK334429 tended to decrease histamine levels in the IVC
of CFA-treated animals. Upon removal of the vascular
endothelium histamine was not detectable in the tissues. The
results provide indication for the implication of the vascular
endothelium in the H3R/H4R-mediated automodulatory
action of histamine in large blood vessels. The role of H3R
and/or H4R in shaping the (patho)physiological vascular
tone and systemic inflammatory responses in blood vessels is
currently under investigation.
This work was supported by the UOA research grant
70/4/8309 of the Greek Ministry of Health and it is part of
the EU-FP7 COST Action BM0806.
Department of Pharmacology, Medical School, University of
Athens, M. Asias 75, GR-11527. E-mail: kkyriak@med.uoa.gr
SARCO(ENDO)PLASMIC RETICULUM
CA(2 +)ATPASE (SERCA) EXPRESSION
IN EXPERIMENTAL HEART ISCHEMIA–
REPERFUSION INJURY: EFFECTS OF
HISTAMINE AND HISTAMINE RECEPTOR
LIGANDS
M. Mussur, J. Kobos, W.A. Fogel
Histamine (HA) exerts inotropic, chronotropic and
arrhythmogenic effects. Sequestration of calcium by the
sarco/endoplasmic reticulum Ca2+-ATPase (SERCA)
mediates muscle relaxation.
SERCA expression was examined immunohistochemi-
cally in guinea pig isolated hearts subjected to ischemia–
reperfusion under conditions corresponding to those in
cardiopulmonary bypass surgery in humans. Hearts were
taken from male guinea pigs (350–450 g) and perfused by
the Langendorff technique in the sequence: initial perfu-
sion (non-working and working heart, each 15 min), 3 min
perfusion with cardioplegic fluid to stop the heart, 40 min
ischemia, and reperfusion (non-working and working heart,
each 15 min). Hemodynamic and metabolic parameters
were recorded by standard techniques. SERCA was visu-
alised in left ventricle specimens by SERCA2 monoclonal
antibodies (NCL-SERCA2, Clone IID8, 1:400 Novocastra)
with a LSAB + HRP (DAKO) detection kit and DAB
chromogen.
HA and all tested ligands altered cardiac rhythm, the
changes being transient and disappearing with reperfusion,
except in the case of mepyramine where the alterations
became more intense and led to ventricular arrest. HA and
H2 agonists increased oxygen consumption ([29), efflux
of HCO3
- ([39) and H+ ([49). HA dose-dependently
increased SERCA activity as visualised by immunostain-
ing. Ciproxifan acted similarly, but weakly, while 2-(3-
trifluoromethylphenyl)histamine, mepyramine, cimetidine
and R-a-methylhistamine led to reduced enzyme expres-
sion. No changes were found with 2-(2-pyridyl)-
ethylamine or dimaprit. The SERCA expression scores
correlated with coronary flow, cardiac output, heart rate,
oxygen consumption, H+ and HCO3
- efflux.
Thus, HA may increase postischemic heart efficiency by
increasing SERCA activity. The effect may be mediated
via H2 and H3 receptors, acting in opposition. SERCA
activation by HA rather than any of H1–H3 receptors may
account for increased aerobic and anaerobic heart metab-
olism during hypoxia.
Cardiosurgery Clinic, Dept. of Pathomorpholog, Medi-
cal University of Lodz, Lodz, Poland. E-mail: miroslaw.
mussur@umed.lodz.pl
IMOPROXIFAN MODULARES AND IL-6 AND
IL-10 PRODUCTION BY PBMC IN PATIENTS
WITH Q-POSITIVE MYOCARDIAL
INFARCTION
S. Oransky, P. Oransky, R. Khanferyan
Inflammatory mechanisms have an important role in the
pathogenesis of ischemic heart disease (IHD) and the
occurrence of acute ischemic syndromes in some cases
results in acute Q-positive myocardial infarction (Q-AMI).
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Recently, research has focused on the roles of histamine
and cytokine activation in the development IHD and AMI.
The purpose of this study was to investigate the impact of
H3/H4 receptors in the modulation of pro-and anti-inflam-
matory cytokine (IL-6 and IL-10) production by PBMC of
patients with Q-AMI. PBMC of 20 Q-AMI patients and 20
healthy volunteers were cultivated with and without the H3/
H4 antagonist, Imoproxifan. The concentrations of IL-10
and IL-6 were measured be ELISA. It was shown that the
spontaneous production of IL-6 was greater (p = 0.03) in
patients—12.3 (5.3; 17.4) than in healthy donors—4.2 (1.4;
6.3); data are given as median (25; 75 percentiles). The
spontaneous production of IL-10, on the contrary was
lowered—2.1 (1; 3.9) in comparison with control—9.8
(5.2; 12.7) pg/ml. Imoproxifan at a high concentration
(10-5 M) significantly reduced (p = 0.02) IL-6 production
from 12.3 to 5.1 (1.3; 7.6) pg/ml and increased IL-10
synthesis up to 14.3 (10.3; 20.6) pg/ml (p = 0.04). Thus, it
was established that histamine via H3/H4 receptors may be
involved in cytokine production in patients with Q-AMI
and may have a possible role in the modulation of the pro-
and anti-inflammatory cytokine balance.
Kuban State Medical University, str. Sedin, 4, Krasno-
dar, 30063, Russia. E-mail: s_oransky@inbox.ru
THE INFLUENCE OF EXOGENOUS
SALSOLINOL ON MAST CELLS, INTERSTITIAL
CELLS OF CAJAL AND MYENTERIC PLEXUS
NEURONS IN THE RAT GUT
M. Kurnik, K. Gil, A. Bugajski, P. Thor
Salsolinol (1-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroiso-
quinoline) is a representative of catechol isoquinoline
derivatives used to induce parkinsonism in rodents. Gas-
trointestinal (GI) impairment is one of the most critical
non-motor features of Parkinson’s disease (PD).
Mast cells (MC) in the GI tract have been found in close
spatial contact with interstitial cells of Cajal (ICC), rec-
ognized as pacemaker cells, and myenteric plexus neurons
(MPN), suggesting their functional interaction. Damage to,
or change in activity of, these cells may result in severe
dysfunction in gut motility. The aim of this study was to
evaluate the effects of salsolinol on MC, intramuscular ICC
and MPN in the rat gastrointestinal tract.
Male Wistar rats (n = 10) were treated with salsolinol
(50 mg/kg/day i.p.) for 3 weeks and an equivalent group
served as a control. Fragments of stomach, duodenum and
large intestine were removed and paraffin-embedded
specimens and longitudinal muscle–myenteric plexus strips
were prepared. The total numbers of MC were evaluated by
toluidene blue staining. Gastric antral, duodenal and
ascending colon intramuscular ICC (anti-c-Kit antibody)
and MPN (anti-PGP9.5 antibody) were assessed by image
analysis.
The total number of MC in the GI wall of the stomach
(98.7 ± 53.3 vs. 156.7 ± 45.8), duodenum (2.6 ± 2.1 vs.
7.8 ± 7.8) and colon (12.8 ± 14.0 vs. 10.7 ± 17.1) were
decreased in the salsolinol group compared to the control.
The area of PGP 9.5-positive cells was lower in all
examined strips of GI wall in comparison with the control
group (by 51, 55, 45%, respectively). The area of cells
stained with anti-c-kit (i.e. cells of Cajal) was lower in the
stomach and duodenum (by 28, 19%, respectively) but no
differences were observed in the colon.
Salsolinol thus exerts its destructive influence over MC,
MPN and ICC in all examined segments of the GI tract.
This may lead to a GI dysfunction. These results may then
provide new insight into the pathophysiology of PD.
Department of Pathophysiology, Jagiellonian University
Medical College, Krakow 31-121, Poland. E-mail:
magdalena.kurnik@gmail.com
HISTAMINE MODULATES BxPC3 CELL LINE
GROWTH AND THE INTERACTION WITH
MICROENVIRONMENT
G.P. Cricco, N.A. Mohamad, M. Croci, J.C. Porretti,
E.S. Rivera, G.A. Martı́n
We have demonstrated that histamine (HA) regulates pro-
cesses related to cell proliferation, differentiation and
invasive ability via the four membrane receptors in various
tumor cell lines. The aim here was to assess the role of HA
in a human pancreatic adenocarcinoma cell line BxPC3.
We determined that HA modulates cell proliferation
using a clonogenic assay. A rise was observed at low doses
of HA (0.5–1 lM) while a decrease was found [20 lM
(182% p \ 0.01 and 65% p \ 0.05). A stimulatory effect
was evoked by the H3 agonist (R)-a-methylhistamine
(151% p \ 0.05) and the H2 agonist amthamine (160%
p \ 0.05); both responses were blocked by the specific
antagonists JNJ5207852 and ranitidine, respectively. Bro-
modeoxiuridin (BrdU) incorporation evaluated by
immunostaining (HA vs. C, p \ 0.05) and cyclin D and E
expression by immunoblot confirmed the increase in num-
ber of cells in S phase of cell cycle when cultures received
low doses of HA or amthamine or (R)-a-methylhistamine.
Conversely the H1 agonist 2-(3-trifluormethylphenyl) his-
tamine and H4 agonists VUF 8430 and clobenpropit
inhibited cell proliferation (60% p \ 0.05) by increasing
apoptosis.
Matrix metalloproteinases secretion and cell migration
are critical for tumor invasion. We found that HA dose
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dependently enhances MMP9 activity assessed by zy-
mography (up to 225% p \ 0.01) and cell migration by
transwell systems (up to 200% p \ 0.05).
BxPC3 cells (s.c.) in nude mice led to the development
of differentiated tumors. Tumors xenografted in HA treated
animals showed a higher growth rate (tumor doubling time:
9 vs. 15 days, p \ 0.05) and a more important stromal
desmoplastic reaction than control animals. In vitro studies
determined that conditioned media from HA treated
BxPC3 cells, increased proliferation of a normal fibroblast
cell line, assayed by PCNA expression and BrdU incor-
poration (210% p \ 0.01).
Pancreatic cancer has a high mortality rate. Thus drugs
that can both regulate tumor cell survival and metastatic
ability will help to delineate more effective strategies for
therapeutic intervention.
Laboratorio de Radioisótopos. Facultad de Farmacia y
Bioquı́mica. Universidad de Buenos Aires. Argentina.
E-mail: gamartin@ffyb.uba.ar
HISTAMINE H4 RECEPTOR EXPRESSON
IN HUMAN NEVUS AND MELANOMA
N. Massari, V.A. Medina, M. Croci, D. Martinel Lamas,
R.M. Bergoc, E.S. Rivera
Malignant melanoma is an aggressive, therapy-resistant
malignancy of melanocytes. The incidence of melanoma
has been steadily growing worldwide, resulting in an
increasing public health problem. The expression of all
histamine receptors (HR) subtypes were demonstrated in
human melanoma cell lines. We have previously shown
that histamine inhibits proliferation and migration, and
induces differentiation and senescence through the activa-
tion of the H4R in WM35 primary and M1/15 highly
metastatic human melanoma cells. The aim of this work
was to investigate the presence of H4R in human nevus and
melanoma skin biopsies and its association with prolifer-
ating cell nuclear antigen (PCNA), histamine and histidine
decarboxylase (HDC) expression levels by immunohisto-
chemistry. The immunohistochemical analysis showed that
H4R was detected in 42% (8/19) of melanoma samples and
in 83% (15/18) of nevi, in which a higher level of
expression was observed (*p = 0.0107, Mann–Whitney’s
two tail test). We additionally evaluated PCNA immuno-
staining as an indicator of active proliferation, and results
demonstrated that only melanomas expressed PCNA,
which inversely correlated with H4R expression
(*p = 0.0158; Sperman r = -0.54). Melanoma tissues
demonstrated higher levels of HDC expression compared
to nevi, while no difference was observed in histamine
content. Present findings indicate that the H4R is expressed
in human melanoma and nevus biopsies, confirming that
the H4R is present not only in cell lines but also in human
skin tissue. The identification of H4R and the clarification
of its role in human malignant melanoma progression may
contribute to the advancement in the treatment of this
disease.
Laboratory of Radioisotopes, School of Pharmacy and
Biochemistry, University of Buenos Aires, Junı́n 956 PB,
1113, Buenos Aires, Argentina. E-mail: erivera@
ffyb.uba.ar
HISTAMINE RECEPTOR LIGANDS AS
POTENTIAL RADIOSENSITIZERS OF HUMAN
BREAST CANCER CELLS
D.J. Martinel Lamas, P.G. Brenzoni, M.A. Nuñez,
N. Massari, E.S. Rivera, V.A. Medina
We have previously demonstrated that histamine (HA)
significantly protects healthy tissues against ionizing
radiation damage in rodents. The aim here was to inves-
tigate whether HA and its ligands could modulate in vitro
radiosensitivity of two breast cancer cell lines, MDA-MB-
231 [estrogen receptor (ER)a-] and MCF-7 (ERa+). Thus
we evaluated the response to gamma radiation using a
Cesium 137 source (0–10 Gy). Cells were treated with
HA and/or specific ligands 24 h before irradiation and
radiobiological parameters, including 2 Gy surviving
fraction (SF2 Gy), were obtained from the survival curves
adjusted to linear quadratic model [SF = e-(aD?bD2)].
Cell apoptosis was determined by the TUNEL assay and
Annexin-V staining, while senescence was investigated
through the activity of b-galactosidase after 2 Gy dose.
Catalase activity and peroxide levels were measured
spectrophotometrically and by flow cytometry, respec-
tively. Results indicate that HA increased radiosensitivity
of MDA-MB-231 (SF2 Gy 0.06 ± 0.02 vs. 0.22 ± 0.04,
p \ 0.01) and MCF-7 cells (FS2 Gy 0.16 ± 0.01 vs.
0.21 ± 0.02, p \ 0.05). In MDA-MB-231 cells, this effect
was mimicked by the H1R agonist 2-(3-(trifluoro-
methyl)phenyl)histamine (SF2 Gy 0.04 ± 0.01) while was
blocked by the combined treatment with mepyramine. In
MCF-7 cells, the main receptor involved was the H4R,
since the H4R agonists (clobenpropit and VUF8430)
reduced the SF 2 GY (0.06 ± 0.02) and JNJ7777120
treatment reversed HA effect. Radiation increased cell
apoptosis and senescence, responses that were enhanced
by HA and its agonists. Also in MDA-MB-231 cells, HA
modulated peroxide levels and catalase activity via the
H1R. We conclude that HA modulates radiosensitivity of
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breast cancer cell lines through different receptor sub-
types, suggesting that the combined use with radiation
could be an attractive strategy to enhance the efficacy of
radiotherapy for breast cancer treatment.
Laboratory of Radioisotopes, School of Pharmacy and
Biochemistry, University of Buenos Aires, Junı́n 956 PB,
Buenos Aires, 1113, Argentina. E-mail: vmedina@
ffyb.uba.ar
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